HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 45820,
"recordsTotal": 45820,
"next": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=-sponsor__name&start=24300",
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=-sponsor__name&start=23700",
"results": [
{
"registry_id": "NCT04947085",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04947085",
"title": "Comparison of Nebulized Ketamine to Intravenous Sub-Dissociative Dose Ketamine for Treating Acute and Chronic Painful Conditions in the ED: A Prospective, Randomized, Double-Blind, Double-Dummy Clinical Trial.",
"has_exemption": false,
"start_date": "2021-10-04",
"completion_date": "2023-09-30",
"has_results": true,
"results_due": true,
"sponsor_name": "Antonios Likourezos",
"sponsor_slug": "antonios-likourezos",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04885972",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04885972",
"title": "A Phase 2, Randomized, Active and Placebo-Controlled, Dose Ranging Study to Evaluate the Efficacy and Safety of Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee Osteoarthritis",
"has_exemption": false,
"start_date": "2021-11-15",
"completion_date": "2023-09-30",
"has_results": false,
"results_due": true,
"sponsor_name": "Sorrento Therapeutics, Inc.",
"sponsor_slug": "sorrento-therapeutics-inc",
"status": "overdue",
"is_pact": false,
"days_late": 322
},
{
"registry_id": "NCT05182502",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05182502",
"title": "A Prospective, Single-center, Single-arm Clinical Study Evaluating the Safety and Effectiveness of the Tixel Fractional System in the Treatment of Photodamage at Low Settings",
"has_exemption": false,
"start_date": "2022-01-07",
"completion_date": "2023-09-30",
"has_results": false,
"results_due": true,
"sponsor_name": "Eric Bernstein, MD",
"sponsor_slug": "eric-bernstein-md",
"status": "overdue",
"is_pact": false,
"days_late": 322
},
{
"registry_id": "NCT05338437",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05338437",
"title": "Neuromuscular Electrical Stimulation in Heart Failure Patients to Improve Functional Recovery Following Hospitalization (NeuHF-Recover)",
"has_exemption": false,
"start_date": "2022-02-07",
"completion_date": "2023-09-30",
"has_results": false,
"results_due": true,
"sponsor_name": "University of Vermont Medical Center",
"sponsor_slug": "university-of-vermont-medical-center",
"status": "reported-late",
"is_pact": false,
"days_late": 119
},
{
"registry_id": "NCT05199818",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05199818",
"title": "Efficacy and Safety of Palonosetron HCl Buccal Film Versus IV Palonosetron for Prevention of Chemotherapy-induced Nausea and Vomiting in Cancer Patients Receiving Moderately Emetogenic Chemotherapy",
"has_exemption": false,
"start_date": "2022-03-01",
"completion_date": "2023-09-30",
"has_results": false,
"results_due": true,
"sponsor_name": "Xiamen LP Pharmaceutical Co., Ltd",
"sponsor_slug": "xiamen-lp-pharmaceutical-co-ltd",
"status": "overdue",
"is_pact": false,
"days_late": 322
},
{
"registry_id": "NCT04982614",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04982614",
"title": "A Multi-site, Open-label Non-inferiority Trial to Assess Immunogenicity of Two Doses of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Children, Adolescents and Young Adults (9-26 Years) Living with HIV Vs Three Doses of Nonavalent HPV Vaccine Among HIV Uninfected Young Women (15-26 Years) in Eswatini",
"has_exemption": false,
"start_date": "2022-04-01",
"completion_date": "2023-09-30",
"has_results": false,
"results_due": true,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "overdue",
"is_pact": false,
"days_late": 322
},
{
"registry_id": "NCT05311215",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05311215",
"title": "A Randomized, Double-Blind, Placebo-Controlled Single Ascending Dose Escalation Study to Assess the Safety, Pharmacokinetics and Efficacy of SL-1002 in Patients With Limb Spasticity",
"has_exemption": false,
"start_date": "2022-04-22",
"completion_date": "2023-09-30",
"has_results": false,
"results_due": true,
"sponsor_name": "Saol Therapeutics Inc",
"sponsor_slug": "saol-therapeutics-inc",
"status": "overdue",
"is_pact": false,
"days_late": 322
},
{
"registry_id": "NCT05300477",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05300477",
"title": "Augmentation of Medical Readiness and Physical Performance at High Altitude Using Pharmacological Countermeasures",
"has_exemption": false,
"start_date": "2022-05-27",
"completion_date": "2023-09-30",
"has_results": false,
"results_due": true,
"sponsor_name": "United States Army Research Institute of Environmental Medicine",
"sponsor_slug": "united-states-army-research-institute-of-environmental-medicine",
"status": "overdue",
"is_pact": false,
"days_late": 322
},
{
"registry_id": "NCT05315739",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05315739",
"title": "Vagus Nerve Stimulation as a Novel Treatment for Systemic Lupus Erythematous: A Double Blinded Randomized Controlled Trail",
"has_exemption": false,
"start_date": "2022-05-31",
"completion_date": "2023-09-30",
"has_results": false,
"results_due": true,
"sponsor_name": "Rigshospitalet, Denmark",
"sponsor_slug": "rigshospitalet-denmark",
"status": "overdue",
"is_pact": false,
"days_late": 322
},
{
"registry_id": "NCT05669521",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05669521",
"title": "A Phase 2a, Multi-centre, Placebo Controlled, Randomized, Assessor Blind Study of Bolus 5-fluorouracil and Infused Leucovorin Plus Either Infused TK-90 for Parenteral Use or Infused TK-90 Placebo Administered Weekly for 6 Consecutive Weeks to Patients With Colorectal Cancer.",
"has_exemption": false,
"start_date": "2022-06-15",
"completion_date": "2023-09-30",
"has_results": false,
"results_due": true,
"sponsor_name": "Tosk, Inc.",
"sponsor_slug": "tosk-inc",
"status": "overdue",
"is_pact": false,
"days_late": 322
},
{
"registry_id": "NCT05658016",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05658016",
"title": "A Phase 2a, Multi-center, Placebo-Controlled, Randomized, Assessor-blind Study to Assess the Safety & Efficacy of Parenteral TK-90 or Parenteral TK-90 Placebo to Patients Receiving Radiotherapy for Non-Metastatic Squamous Cell Carcinoma of Head and Neck.",
"has_exemption": false,
"start_date": "2022-06-17",
"completion_date": "2023-09-30",
"has_results": false,
"results_due": true,
"sponsor_name": "Tosk, Inc.",
"sponsor_slug": "tosk-inc",
"status": "overdue",
"is_pact": false,
"days_late": 322
},
{
"registry_id": "NCT05297799",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05297799",
"title": "Clinical Validation of the Ameda Pearl Breast Pump",
"has_exemption": false,
"start_date": "2022-07-21",
"completion_date": "2023-09-30",
"has_results": false,
"results_due": true,
"sponsor_name": "Ameda, Inc.",
"sponsor_slug": "ameda-inc",
"status": "overdue",
"is_pact": false,
"days_late": 322
},
{
"registry_id": "NCT05178927",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05178927",
"title": "UFPTI 2105-BR05: Improving Breast Radiotherapy Setup and Delivery Using Mixed-Reality Visualization",
"has_exemption": false,
"start_date": "2022-08-02",
"completion_date": "2023-09-30",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05542576",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05542576",
"title": "Prospective Randomized Open, Blinded Endpoint (PROBE) Study of AMDX-2011P as a Retinal Tracer in Subjects With Neurodegenerative Diseases Associated With Amyloidogenic Proteinopathy",
"has_exemption": false,
"start_date": "2022-08-24",
"completion_date": "2023-09-30",
"has_results": false,
"results_due": true,
"sponsor_name": "Amydis Inc.",
"sponsor_slug": "amydis-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 307
},
{
"registry_id": "NCT05789849",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05789849",
"title": "Data Collection for Validation of a Noninvasive Blood Pressure Auscultatory Algorithm - Pregnant Women",
"has_exemption": false,
"start_date": "2022-09-14",
"completion_date": "2023-09-30",
"has_results": false,
"results_due": true,
"sponsor_name": "GE Healthcare",
"sponsor_slug": "ge-healthcare",
"status": "overdue",
"is_pact": false,
"days_late": 322
},
{
"registry_id": "NCT05610787",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05610787",
"title": "EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study",
"has_exemption": false,
"start_date": "2022-11-14",
"completion_date": "2023-09-30",
"has_results": false,
"results_due": true,
"sponsor_name": "Berlin Heart, Inc",
"sponsor_slug": "berlin-heart-inc",
"status": "overdue",
"is_pact": false,
"days_late": 322
},
{
"registry_id": "NCT05621031",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05621031",
"title": "Effects of Whole Body Vibration in Parkinson's Disease Symptoms",
"has_exemption": false,
"start_date": "2023-01-01",
"completion_date": "2023-09-30",
"has_results": false,
"results_due": true,
"sponsor_name": "University of Seville",
"sponsor_slug": "university-of-seville",
"status": "overdue",
"is_pact": false,
"days_late": 322
},
{
"registry_id": "NCT05705518",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05705518",
"title": "Effects Of Artificial Tears on Tear Lipid Films and Tear Film Dynamics In Vivo",
"has_exemption": false,
"start_date": "2023-01-30",
"completion_date": "2023-09-30",
"has_results": true,
"results_due": true,
"sponsor_name": "University of California, Berkeley",
"sponsor_slug": "university-of-california-berkeley",
"status": "reported-late",
"is_pact": false,
"days_late": 106
},
{
"registry_id": "NCT05372094",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05372094",
"title": "Noise Reduction Preferences in Teenagers and Pre-teens",
"has_exemption": false,
"start_date": "2023-02-23",
"completion_date": "2023-09-30",
"has_results": true,
"results_due": true,
"sponsor_name": "Sonova AG",
"sponsor_slug": "sonova-ag",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05465226",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05465226",
"title": "A pRospective, Case-controlled Evaluation of oLIceridine for Moderate or sEVEre Pain in Patients With Acute Burn Injuries. (RELIEVE)",
"has_exemption": false,
"start_date": "2023-04-01",
"completion_date": "2023-09-30",
"has_results": false,
"results_due": true,
"sponsor_name": "University of Tennessee",
"sponsor_slug": "university-of-tennessee",
"status": "overdue",
"is_pact": false,
"days_late": 322
},
{
"registry_id": "NCT05882019",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05882019",
"title": "Evaluation of the \"Bexa™\" Breast Examination (BBE) as an Effective Solution to Breast Cancer Early Detection",
"has_exemption": false,
"start_date": "2023-05-31",
"completion_date": "2023-09-30",
"has_results": false,
"results_due": true,
"sponsor_name": "Sure, Inc.",
"sponsor_slug": "sure-inc",
"status": "overdue",
"is_pact": false,
"days_late": 322
},
{
"registry_id": "NCT05918341",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05918341",
"title": "The Feasibility of Using a Subtherapeutic Dose of Piracetam as a Marker of Adherence to Therapy",
"has_exemption": false,
"start_date": "2023-07-03",
"completion_date": "2023-09-30",
"has_results": false,
"results_due": true,
"sponsor_name": "The Netherlands Cancer Institute",
"sponsor_slug": "the-netherlands-cancer-institute",
"status": "overdue",
"is_pact": false,
"days_late": 322
},
{
"registry_id": "NCT04851886",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04851886",
"title": "PostureCheck: A Vision-based Compensatory-posture-detection Tool to Enhance Performance of the BURT Upper-extremity Stroke-therapy",
"has_exemption": false,
"start_date": "2023-09-01",
"completion_date": "2023-09-30",
"has_results": false,
"results_due": true,
"sponsor_name": "Spaulding Rehabilitation Hospital",
"sponsor_slug": "spaulding-rehabilitation-hospital",
"status": "overdue",
"is_pact": false,
"days_late": 322
},
{
"registry_id": "NCT02357797",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02357797",
"title": "Adjunctive Vortioxetine in Schizophrenia",
"has_exemption": false,
"start_date": "2016-02-29",
"completion_date": "2023-10-01",
"has_results": false,
"results_due": true,
"sponsor_name": "Northwell Health",
"sponsor_slug": "northwell-health",
"status": "overdue",
"is_pact": true,
"days_late": 321
},
{
"registry_id": "NCT05166746",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05166746",
"title": "A Double-blind, Placebo-controlled Multicenter Trial on the Effect of Clindamycin and a Live Biotherapeutic on the Reproductive Outcomes of IVF Patients With Abnormal Vaginal Microbiota",
"has_exemption": false,
"start_date": "2017-12-07",
"completion_date": "2023-10-01",
"has_results": false,
"results_due": true,
"sponsor_name": "Peter Humaidan",
"sponsor_slug": "peter-humaidan",
"status": "overdue",
"is_pact": false,
"days_late": 321
},
{
"registry_id": "NCT06623175",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06623175",
"title": "Effects of Acupuncture in Spontaneous Rapture of Membranes: Applicability and Effectiveness",
"has_exemption": false,
"start_date": "2018-07-05",
"completion_date": "2023-10-01",
"has_results": false,
"results_due": true,
"sponsor_name": "Prof. Fabio Facchinetti",
"sponsor_slug": "prof-fabio-facchinetti",
"status": "overdue",
"is_pact": false,
"days_late": 321
},
{
"registry_id": "NCT03702582",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03702582",
"title": "Trial of New Oral Anticoagulants vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation",
"has_exemption": false,
"start_date": "2019-04-30",
"completion_date": "2023-10-01",
"has_results": false,
"results_due": true,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "overdue",
"is_pact": false,
"days_late": 321
},
{
"registry_id": "NCT04002141",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04002141",
"title": "Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis",
"has_exemption": false,
"start_date": "2019-09-17",
"completion_date": "2023-10-01",
"has_results": false,
"results_due": true,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "reported-late",
"is_pact": false,
"days_late": 52
},
{
"registry_id": "NCT04083690",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04083690",
"title": "Multi-lead ECG to Effectively Optimize Resynchronization Devices: New CRT Recipients",
"has_exemption": false,
"start_date": "2019-10-11",
"completion_date": "2023-10-01",
"has_results": false,
"results_due": true,
"sponsor_name": "Allina Health System",
"sponsor_slug": "allina-health-system",
"status": "overdue",
"is_pact": false,
"days_late": 321
},
{
"registry_id": "NCT03623256",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03623256",
"title": "Comparison of Intrathecal Versus Epidural Fentanyl: Effect of Neuraxial Route of Administration on Fetal Bradycardia in Labor Combined Spinal Epidural Analgesia",
"has_exemption": false,
"start_date": "2019-10-28",
"completion_date": "2023-10-01",
"has_results": false,
"results_due": true,
"sponsor_name": "Augusta University",
"sponsor_slug": "augusta-university",
"status": "overdue",
"is_pact": false,
"days_late": 321
},
{
"registry_id": "NCT04224311",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04224311",
"title": "Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine in Frequent Platelets Donors",
"has_exemption": false,
"start_date": "2020-03-12",
"completion_date": "2023-10-01",
"has_results": false,
"results_due": true,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "overdue",
"is_pact": false,
"days_late": 321
},
{
"registry_id": "NCT04424693",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04424693",
"title": "A Prospective Randomized Clinical Research Trial Comparing the Incidence of Preeclampsia Between Pregnant Women Receiving Tdap Vaccinations at Week 28 and Those Receiving Tdap Vaccinations at Week 36",
"has_exemption": false,
"start_date": "2020-12-01",
"completion_date": "2023-10-01",
"has_results": false,
"results_due": true,
"sponsor_name": "Institute of Arthritis Research",
"sponsor_slug": "institute-of-arthritis-research",
"status": "overdue",
"is_pact": false,
"days_late": 321
},
{
"registry_id": "NCT05153629",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05153629",
"title": "Noninvasive Electrical Stimulator as an Adjunct for Pain Control After Ureteroscopic Stone Management",
"has_exemption": false,
"start_date": "2021-01-10",
"completion_date": "2023-10-01",
"has_results": true,
"results_due": true,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04979442",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04979442",
"title": "A Randomized Multicenter Phase 3 Study of Milademetan Versus Trabectedin in Patients With Dedifferentiated Liposarcoma",
"has_exemption": false,
"start_date": "2021-07-14",
"completion_date": "2023-10-01",
"has_results": true,
"results_due": true,
"sponsor_name": "Rain Oncology Inc",
"sponsor_slug": "rain-oncology-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04922255",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04922255",
"title": "Pilot Trial of Non-Surgical Management for Women With Cystic Fibrosis and Urinary Incontinence",
"has_exemption": false,
"start_date": "2021-09-01",
"completion_date": "2023-10-01",
"has_results": true,
"results_due": true,
"sponsor_name": "Megan Bradley",
"sponsor_slug": "megan-bradley",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05110053",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05110053",
"title": "Spinal Cord sTimulation thEraPy for Parkinson's Disease Patients With Gait Problems",
"has_exemption": false,
"start_date": "2021-09-01",
"completion_date": "2023-10-01",
"has_results": false,
"results_due": true,
"sponsor_name": "University of Aarhus",
"sponsor_slug": "university-of-aarhus",
"status": "overdue",
"is_pact": false,
"days_late": 321
},
{
"registry_id": "NCT05057247",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05057247",
"title": "A Phase II Study of Duvelisib Plus Docetaxel in PD-1 Inhibitor Experienced Patients With Incurable Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2021-10-14",
"completion_date": "2023-10-01",
"has_results": true,
"results_due": true,
"sponsor_name": "Glenn J. Hanna",
"sponsor_slug": "glenn-j-hanna",
"status": "reported-late",
"is_pact": false,
"days_late": 113
},
{
"registry_id": "NCT05046730",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05046730",
"title": "SEAM Trial: Sutureless End to End Anastomosis by Magnetic Compression: A Study to Evaluate Safety and Effectiveness of Self-Forming Magnet (SFM) Anastomosis Device: A Historically Controlled Propensity Matched Study",
"has_exemption": false,
"start_date": "2022-02-01",
"completion_date": "2023-10-01",
"has_results": false,
"results_due": true,
"sponsor_name": "GI Windows, Inc.",
"sponsor_slug": "gi-windows-inc",
"status": "overdue",
"is_pact": false,
"days_late": 321
},
{
"registry_id": "NCT05200858",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05200858",
"title": "Transcutaneous Electrical Nerve Stimulation For Lower Extremity In Patients With Neurogenic Pain - A Proof Of Concept Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2022-03-01",
"completion_date": "2023-10-01",
"has_results": true,
"results_due": true,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05228899",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05228899",
"title": "A Phase I/II Multicenter, Randomized, Double Blinded, Placebo Trial to Evaluate the Safety and Potential Efficacy of Zofin Infused Intravenous (IV) in Patients Experiencing Prolonged COVID-19 Symptoms (Long-Haulers) vs Placebo.",
"has_exemption": false,
"start_date": "2022-04-14",
"completion_date": "2023-10-01",
"has_results": false,
"results_due": true,
"sponsor_name": "ZEO ScientifiX, Inc.",
"sponsor_slug": "zeo-scientifix-inc",
"status": "overdue",
"is_pact": false,
"days_late": 321
},
{
"registry_id": "NCT05378867",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05378867",
"title": "A Phase 3, Multicenter, Randomized and Double-blind Study Assessing the Interchangeability Between TRS003 and China-approved Bevacizumab® (Also Called China-approved Avastin) For First-Line Treatment of Patients With Metastatic Colorectal Cancer (CRC)",
"has_exemption": false,
"start_date": "2022-08-01",
"completion_date": "2023-10-01",
"has_results": false,
"results_due": true,
"sponsor_name": "Zhejiang Teruisi Pharmaceutical Inc.",
"sponsor_slug": "zhejiang-teruisi-pharmaceutical-inc",
"status": "overdue",
"is_pact": false,
"days_late": 321
},
{
"registry_id": "NCT05553613",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05553613",
"title": "Ticagrelor Versus Clopidogrel in Ischemic Stroke. a Randomized Double-blinded Controlled Trial",
"has_exemption": false,
"start_date": "2022-10-01",
"completion_date": "2023-10-01",
"has_results": false,
"results_due": true,
"sponsor_name": "Kafrelsheikh University",
"sponsor_slug": "kafrelsheikh-university",
"status": "overdue",
"is_pact": false,
"days_late": 321
},
{
"registry_id": "NCT05605327",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05605327",
"title": "A Multicentre Cohort Study and a Randomized Controlled Trial of EUS-guided Versus LaparOscopic GAsTrojejunostomY for malIgNant Gastric Outlet Obstruction: EATING Trial",
"has_exemption": false,
"start_date": "2022-11-01",
"completion_date": "2023-10-01",
"has_results": false,
"results_due": true,
"sponsor_name": "Universitaire Ziekenhuizen KU Leuven",
"sponsor_slug": "universitaire-ziekenhuizen-ku-leuven",
"status": "overdue",
"is_pact": false,
"days_late": 321
},
{
"registry_id": "NCT05714670",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05714670",
"title": "The Effect of Curcumin on the Clinical Outcome of Pediatric Patients with Active Lupus Nephritis",
"has_exemption": false,
"start_date": "2023-04-01",
"completion_date": "2023-10-01",
"has_results": false,
"results_due": true,
"sponsor_name": "Ain Shams University",
"sponsor_slug": "ain-shams-university",
"status": "overdue",
"is_pact": false,
"days_late": 321
},
{
"registry_id": "NCT05875610",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05875610",
"title": "Clinical Study on Chemotherapy Induced Peripheral Neuropathy: Preventive Approach Using Venlafaxine",
"has_exemption": false,
"start_date": "2023-05-01",
"completion_date": "2023-10-01",
"has_results": false,
"results_due": true,
"sponsor_name": "Mit Ghamr Oncology Center",
"sponsor_slug": "mit-ghamr-oncology-center",
"status": "overdue",
"is_pact": false,
"days_late": 321
},
{
"registry_id": "NCT02850406",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02850406",
"title": "A Phase 2a, Open-label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Treatment Effect of GBT440 in Pediatric Participants With Sickle Cell Disease",
"has_exemption": false,
"start_date": "2016-07-05",
"completion_date": "2023-10-02",
"has_results": true,
"results_due": true,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "reported-late",
"is_pact": true,
"days_late": 226
},
{
"registry_id": "NCT03277196",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03277196",
"title": "A Phase 3, 2-Arm, Open-label Study to Evaluate the Safety and Pharmacodynamics of Long-term Ivacaftor Treatment in Subjects With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation",
"has_exemption": false,
"start_date": "2017-08-16",
"completion_date": "2023-10-02",
"has_results": true,
"results_due": true,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03428802",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03428802",
"title": "A Basket Trial of Pembrolizumab in Patients With Advanced Solid Tumors and Genomic Instability",
"has_exemption": false,
"start_date": "2018-03-08",
"completion_date": "2023-10-02",
"has_results": false,
"results_due": true,
"sponsor_name": "Rutgers, The State University of New Jersey",
"sponsor_slug": "rutgers-the-state-university-of-new-jersey",
"status": "overdue",
"is_pact": false,
"days_late": 320
},
{
"registry_id": "NCT03884101",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03884101",
"title": "A Phase 3 Randomized, Open-Label, Study of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for First-line Treatment of Advanced or Recurrent Endometrial Carcinoma (LEAP-001)",
"has_exemption": false,
"start_date": "2019-04-11",
"completion_date": "2023-10-02",
"has_results": true,
"results_due": true,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03916068",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03916068",
"title": "A Pilot Study Comparing Acute Post-Radiation Hyperbaric Oxygen (HBO2) Versus Trental and Vitamin E for Breast Cancer Patients Who Have Recently Completed Radiation Therapy as Part of Their Treatment Course",
"has_exemption": false,
"start_date": "2019-07-01",
"completion_date": "2023-10-02",
"has_results": false,
"results_due": true,
"sponsor_name": "Legacy Health System",
"sponsor_slug": "legacy-health-system",
"status": "overdue",
"is_pact": false,
"days_late": 320
},
{
"registry_id": "NCT06026683",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06026683",
"title": "Conduction System Stimulation to Avoid Left Ventricle Dysfunction",
"has_exemption": false,
"start_date": "2019-09-30",
"completion_date": "2023-10-02",
"has_results": false,
"results_due": true,
"sponsor_name": "Parc de Salut Mar",
"sponsor_slug": "parc-de-salut-mar",
"status": "overdue",
"is_pact": false,
"days_late": 320
},
{
"registry_id": "NCT04865289",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04865289",
"title": "A Phase 3 Randomized, Open-Label, Study of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for First-line Treatment of Advanced or Recurrent Endometrial Carcinoma (LEAP-001)",
"has_exemption": false,
"start_date": "2019-10-22",
"completion_date": "2023-10-02",
"has_results": true,
"results_due": true,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03803683",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03803683",
"title": "mLab App for Improving Uptake of Rapid HIV Self-testing and Linking Youth to Care",
"has_exemption": false,
"start_date": "2020-01-21",
"completion_date": "2023-10-02",
"has_results": true,
"results_due": true,
"sponsor_name": "Rebecca Schnall, RN, MPH, PhD",
"sponsor_slug": "rebecca-schnall-rn-mph-phd",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04246047",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04246047",
"title": "DREAMM 7: A Multicenter, Open-Label, Randomized Phase III Study to Evaluate the Efficacy and Safety of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (B-Vd) Compared With the Combination of Daratumumab, Bortezomib and Dexamethasone (D-Vd) in Participants With Relapsed/Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2020-05-07",
"completion_date": "2023-10-02",
"has_results": true,
"results_due": true,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04338022",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04338022",
"title": "A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared With Teriflunomide, in Participants With Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety (evolutionRMS 1)",
"has_exemption": false,
"start_date": "2020-06-12",
"completion_date": "2023-10-02",
"has_results": true,
"results_due": true,
"sponsor_name": "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany",
"sponsor_slug": "merck-healthcare-kgaa-darmstadt-germany-an-affiliate-of-merck-kgaa-darmstadt-germany",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04338061",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04338061",
"title": "A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared With Teriflunomide, in Participants With Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety (evolutionRMS 2)",
"has_exemption": false,
"start_date": "2020-07-02",
"completion_date": "2023-10-02",
"has_results": true,
"results_due": true,
"sponsor_name": "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany",
"sponsor_slug": "merck-healthcare-kgaa-darmstadt-germany-an-affiliate-of-merck-kgaa-darmstadt-germany",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04832724",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04832724",
"title": "A Phase 2, Open-label Study to Explore the Pharmacodynamics of Two Doses in Two Formulations of RGX-314 Gene Therapy Administered Via Subretinal Delivery in Participants With Neovascular Age-related Macular Degeneration",
"has_exemption": true,
"start_date": "2021-02-22",
"completion_date": "2023-10-02",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04647253",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04647253",
"title": "AGENT IDE: A Prospective, Randomized (2:1), Multicenter Trial to Assess the Safety and Effectiveness of the AgentTM Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)",
"has_exemption": false,
"start_date": "2021-05-11",
"completion_date": "2023-10-02",
"has_results": true,
"results_due": true,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04598828",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04598828",
"title": "Using Time Varying Non-Invasive Neuromodulation to Improve Neurovascular Status in Parkinson's Disease",
"has_exemption": false,
"start_date": "2021-07-06",
"completion_date": "2023-10-02",
"has_results": true,
"results_due": true,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "reported-late",
"is_pact": false,
"days_late": 265
},
{
"registry_id": "NCT04906421",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04906421",
"title": "A Phase 2B, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (FASCINATE-2)",
"has_exemption": false,
"start_date": "2021-08-12",
"completion_date": "2023-10-02",
"has_results": true,
"results_due": true,
"sponsor_name": "Sagimet Biosciences Inc.",
"sponsor_slug": "sagimet-biosciences-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 208
},
{
"registry_id": "NCT05087030",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05087030",
"title": "A Randomised, Double Blind, Multicentre Phase III Study to Assess the Efficacy and Safety of RGB-14-P Compared to Prolia® in Women With Postmenopausal Osteoporosis",
"has_exemption": false,
"start_date": "2021-09-21",
"completion_date": "2023-10-02",
"has_results": true,
"results_due": true,
"sponsor_name": "Gedeon Richter Plc.",
"sponsor_slug": "gedeon-richter-plc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06399471",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06399471",
"title": "Personalizing MPK Prescription for Individuals With Transfemoral Amputation",
"has_exemption": false,
"start_date": "2021-10-25",
"completion_date": "2023-10-02",
"has_results": true,
"results_due": true,
"sponsor_name": "Georgia Institute of Technology",
"sponsor_slug": "georgia-institute-of-technology",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04722003",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04722003",
"title": "Mucosal Immune Responses Against Neisseria Gonorrhoeae Following Meningococcal Immunization in Healthy Young Adults",
"has_exemption": false,
"start_date": "2021-11-01",
"completion_date": "2023-10-02",
"has_results": true,
"results_due": true,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05593432",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05593432",
"title": "A Randomized, Double-Blind, Vehicle-Controlled Study of the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus",
"has_exemption": false,
"start_date": "2022-11-23",
"completion_date": "2023-10-02",
"has_results": true,
"results_due": true,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05211284",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05211284",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of Saroglitazar Magnesium for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With Human Immunodeficiency Virus (HIV) in the US",
"has_exemption": true,
"start_date": "2022-12-08",
"completion_date": "2023-10-02",
"has_results": true,
"results_due": false,
"sponsor_name": "Zydus Therapeutics Inc.",
"sponsor_slug": "zydus-therapeutics-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05875727",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05875727",
"title": "A PHASE 3, SINGLE-ARM, MULTICENTER TRIAL TO DESCRIBE THE SAFETY AND IMMUNOGENICITY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN PNEUMOCOCCAL VACCINE-NAÏVE ADULTS ≥18 YEARS OF AGE IN INDIA",
"has_exemption": false,
"start_date": "2023-08-16",
"completion_date": "2023-10-02",
"has_results": true,
"results_due": true,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03632941",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03632941",
"title": "A Phase II Randomized Study to Evaluate the Immunologic and Antitumor Activity of Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Advanced HER2-overexpressing Breast Cancer",
"has_exemption": false,
"start_date": "2019-03-01",
"completion_date": "2023-10-03",
"has_results": true,
"results_due": true,
"sponsor_name": "Herbert Lyerly",
"sponsor_slug": "herbert-lyerly",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04247542",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04247542",
"title": "ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection: A Phase 2A Open-Label Segment Followed by a Phase 2B Double-Blind Vancomycin-Controlled Segment",
"has_exemption": false,
"start_date": "2020-03-06",
"completion_date": "2023-10-03",
"has_results": true,
"results_due": true,
"sponsor_name": "Acurx Pharmaceuticals Inc.",
"sponsor_slug": "acurx-pharmaceuticals-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 48
},
{
"registry_id": "NCT04502862",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04502862",
"title": "A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma",
"has_exemption": false,
"start_date": "2020-08-10",
"completion_date": "2023-10-03",
"has_results": true,
"results_due": true,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04513912",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04513912",
"title": "Double-Blind, Randomized, Parallel-Group Study With Quetiapine Extended Release as Comparator to Evaluate the Efficacy and Safety of Seltorexant 20 mg as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy",
"has_exemption": true,
"start_date": "2020-09-15",
"completion_date": "2023-10-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04659174",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04659174",
"title": "An Open-label Extension Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Subjects With DSM-5 Schizophrenia",
"has_exemption": false,
"start_date": "2021-02-01",
"completion_date": "2023-10-03",
"has_results": true,
"results_due": true,
"sponsor_name": "Karuna Therapeutics",
"sponsor_slug": "karuna-therapeutics",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04311632",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04311632",
"title": "A 12-Month, Randomized, Controlled, Open-Label, Dose Escalation Study Evaluating Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of an Anti-CD2 Monoclonal Antibody, TCD601(Siplizumab) Compared to Anti-thymocyte Globulin (rATG), as Induction Therapy in de Novo Renal Transplant Recipients",
"has_exemption": false,
"start_date": "2021-05-26",
"completion_date": "2023-10-03",
"has_results": true,
"results_due": true,
"sponsor_name": "ITB-Med LLC",
"sponsor_slug": "itb-med-llc",
"status": "reported-late",
"is_pact": false,
"days_late": 126
},
{
"registry_id": "NCT05506969",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05506969",
"title": "Phase 2, Randomized, Active-Controlled, Observer-Blinded, Multicenter Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age",
"has_exemption": false,
"start_date": "2022-08-09",
"completion_date": "2023-10-03",
"has_results": true,
"results_due": true,
"sponsor_name": "Dynavax Technologies Corporation",
"sponsor_slug": "dynavax-technologies-corporation",
"status": "reported-late",
"is_pact": false,
"days_late": 204
},
{
"registry_id": "NCT05513391",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05513391",
"title": "Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine Compared With Egg-Based Standard-Dose Quadrivalent Influenza Vaccine in Children 3 to 8 Years of Age.",
"has_exemption": false,
"start_date": "2022-11-10",
"completion_date": "2023-10-03",
"has_results": true,
"results_due": true,
"sponsor_name": "Sanofi Pasteur, a Sanofi Company",
"sponsor_slug": "sanofi-pasteur-a-sanofi-company",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03115424",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03115424",
"title": "Effect of GLP-1 Receptor Agonism on Weight and Caloric Intake in Subjects After Sleeve Gastrectomy",
"has_exemption": false,
"start_date": "2017-06-22",
"completion_date": "2023-10-04",
"has_results": true,
"results_due": true,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03554265",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03554265",
"title": "Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy",
"has_exemption": false,
"start_date": "2018-08-06",
"completion_date": "2023-10-04",
"has_results": true,
"results_due": true,
"sponsor_name": "The University of Texas Medical Branch, Galveston",
"sponsor_slug": "the-university-of-texas-medical-branch-galveston",
"status": "reported-late",
"is_pact": false,
"days_late": 101
},
{
"registry_id": "NCT03768414",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03768414",
"title": "A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers",
"has_exemption": false,
"start_date": "2019-02-07",
"completion_date": "2023-10-04",
"has_results": true,
"results_due": true,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03865940",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03865940",
"title": "A Randomized, Double-Blind, 2-Way Crossover Trial to Assess the Efficacy of Guanfacine and Lidocaine Combination Versus Lidocaine Alone in Trigeminal Nerve Block for Pain Management in Painful Trigeminal Neuropathy Patients",
"has_exemption": false,
"start_date": "2019-11-04",
"completion_date": "2023-10-04",
"has_results": true,
"results_due": true,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04633460",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04633460",
"title": "Acute Effects of Exogenous Ketone Ester Administration in Heart Failure",
"has_exemption": false,
"start_date": "2020-10-06",
"completion_date": "2023-10-04",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "reported-late",
"is_pact": false,
"days_late": 3
},
{
"registry_id": "NCT04702568",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04702568",
"title": "A Phase 2, Open-Label Study to Evaluate the Long-term Safety of Oral BCX9930 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)",
"has_exemption": false,
"start_date": "2020-12-18",
"completion_date": "2023-10-04",
"has_results": true,
"results_due": true,
"sponsor_name": "BioCryst Pharmaceuticals",
"sponsor_slug": "biocryst-pharmaceuticals",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04816643",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04816643",
"title": "A PHASE 1, OPEN-LABEL DOSE-FINDING STUDY TO EVALUATE SAFETY, TOLERABILITY, AND IMMUNOGENICITY AND PHASE 2/3 PLACEBO-CONTROLLED, OBSERVER-BLINDED SAFETY, TOLERABILITY, AND IMMUNOGENICITY STUDY OF A SARS-COV-2 RNA VACCINE CANDIDATE AGAINST COVID-19 IN HEALTHY CHILDREN",
"has_exemption": false,
"start_date": "2021-03-24",
"completion_date": "2023-10-04",
"has_results": false,
"results_due": true,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04994431",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04994431",
"title": "Post-Operative Urinary Retention (POUR) in Thoracic Surgery Patients Receiving Prophylactic Tamsulosin",
"has_exemption": false,
"start_date": "2021-08-01",
"completion_date": "2023-10-04",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Massachusetts, Worcester",
"sponsor_slug": "university-of-massachusetts-worcester",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05005845",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05005845",
"title": "A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Phase 2 Dose-Response Study to Determine Safety and Effectiveness of Two Concentrations of NFX-179 Gel in Subjects With Cutaneous Neurofibromas",
"has_exemption": false,
"start_date": "2021-09-20",
"completion_date": "2023-10-04",
"has_results": false,
"results_due": true,
"sponsor_name": "NFlection Therapeutics, Inc.",
"sponsor_slug": "nflection-therapeutics-inc",
"status": "overdue",
"is_pact": false,
"days_late": 318
},
{
"registry_id": "NCT05096221",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05096221",
"title": "A Phase 3 Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9001 in Subjects With Duchenne Muscular Dystrophy (EMBARK)",
"has_exemption": false,
"start_date": "2021-10-27",
"completion_date": "2023-10-04",
"has_results": true,
"results_due": true,
"sponsor_name": "Sarepta Therapeutics, Inc.",
"sponsor_slug": "sarepta-therapeutics-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05203315",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05203315",
"title": "A Multicenter, Single-Arm, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults",
"has_exemption": false,
"start_date": "2022-01-13",
"completion_date": "2023-10-04",
"has_results": false,
"results_due": true,
"sponsor_name": "Austin Institute for Clinical Research",
"sponsor_slug": "austin-institute-for-clinical-research",
"status": "overdue",
"is_pact": false,
"days_late": 318
},
{
"registry_id": "NCT05324397",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05324397",
"title": "Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis - A Prospective, Single-arm, Multicenter Clinical Study",
"has_exemption": false,
"start_date": "2022-03-14",
"completion_date": "2023-10-04",
"has_results": false,
"results_due": true,
"sponsor_name": "Neurent Medical",
"sponsor_slug": "neurent-medical",
"status": "overdue",
"is_pact": false,
"days_late": 318
},
{
"registry_id": "NCT05412979",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05412979",
"title": "A Multicenter, Randomized, Double-Blind, Crossover, Phase 2 Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy With ST-1891 Compared to Levothyroxine in Patients With Primary Hypothyroidism",
"has_exemption": false,
"start_date": "2022-04-29",
"completion_date": "2023-10-04",
"has_results": false,
"results_due": true,
"sponsor_name": "Sention Therapeutics, LLC",
"sponsor_slug": "sention-therapeutics-llc",
"status": "overdue",
"is_pact": false,
"days_late": 318
},
{
"registry_id": "NCT05375760",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05375760",
"title": "A Phase II Randomized, Open-label, Multicenter, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, a Combination Product of Two Monoclonal Antibodies (Tixagevimab and Cilgavimab), for Pre-exposure Prophylaxis of COVID-19",
"has_exemption": false,
"start_date": "2022-06-09",
"completion_date": "2023-10-04",
"has_results": true,
"results_due": true,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05386030",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05386030",
"title": "A Randomized, Subject- and Evaluator-blinded, Controlled, Non-inferiority Multicenter, Parallel Group Comparison Study to Evaluate Effectiveness and Safety of Saypha® VOLUME Lidocaine for Midface Augmentation to Correct Volume Deficit",
"has_exemption": false,
"start_date": "2022-08-16",
"completion_date": "2023-10-04",
"has_results": true,
"results_due": true,
"sponsor_name": "Croma-Pharma GmbH",
"sponsor_slug": "croma-pharma-gmbh",
"status": "reported-late",
"is_pact": false,
"days_late": 76
},
{
"registry_id": "NCT02118584",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02118584",
"title": "An Open-Label Extension and Safety Monitoring Study of Moderate to Severe Ulcerative Colitis Patients Previously Enrolled in Etrolizumab Phase II/III Studies",
"has_exemption": false,
"start_date": "2014-09-15",
"completion_date": "2023-10-05",
"has_results": true,
"results_due": true,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03845517",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03845517",
"title": "A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY PROFILE OF PF-06700841 IN PARTICIPANTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)",
"has_exemption": false,
"start_date": "2019-04-18",
"completion_date": "2023-10-05",
"has_results": true,
"results_due": true,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04562896",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04562896",
"title": "Iterative Design of Custom Dynamic Orthoses to Reduce Articular Contact Stress",
"has_exemption": false,
"start_date": "2020-01-08",
"completion_date": "2023-10-05",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Iowa",
"sponsor_slug": "university-of-iowa",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04075266",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04075266",
"title": "An Open-Label, Parallel-Group Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis",
"has_exemption": false,
"start_date": "2020-01-09",
"completion_date": "2023-10-05",
"has_results": true,
"results_due": true,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "reported-late",
"is_pact": false,
"days_late": 11
},
{
"registry_id": "NCT04847921",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04847921",
"title": "Preliminary Evaluation of Dalbavancin's Efficacy in People Who Use Drugs With Severe Gram-positive Infections",
"has_exemption": false,
"start_date": "2021-04-30",
"completion_date": "2023-10-05",
"has_results": false,
"results_due": true,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "overdue",
"is_pact": false,
"days_late": 317
},
{
"registry_id": "NCT04809974",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04809974",
"title": "Randomized, Placebo-controlled Parallel Group Clinical Trial of Nicotinamide Riboside to Evaluate NAD+ Levels in Individuals With Persistent Cognitive and Physical Symptoms After COVID-19 Illness (\"Long-COVID\")",
"has_exemption": false,
"start_date": "2021-08-28",
"completion_date": "2023-10-05",
"has_results": true,
"results_due": true,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "reported-late",
"is_pact": false,
"days_late": 188
},
{
"registry_id": "NCT04865978",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04865978",
"title": "Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices",
"has_exemption": false,
"start_date": "2021-12-14",
"completion_date": "2023-10-05",
"has_results": true,
"results_due": true,
"sponsor_name": "Palak Shah",
"sponsor_slug": "palak-shah",
"status": "reported-late",
"is_pact": false,
"days_late": 16
},
{
"registry_id": "NCT05401565",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05401565",
"title": "A Phase II, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Parallel-Group, Multicenter Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder",
"has_exemption": false,
"start_date": "2022-08-02",
"completion_date": "2023-10-05",
"has_results": true,
"results_due": true,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01801072",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01801072",
"title": "Seizure Prophylaxis in Aneurysm Repair",
"has_exemption": false,
"start_date": "2013-02-28",
"completion_date": "2023-10-06",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02907099",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02907099",
"title": "A Phase IIb Pilot Study to Assess the Efficacy, Safety, and Pharmacodynamics Effects of Pembrolizumab and BL-8040 in Patients With Metastatic Pancreatic Cancer",
"has_exemption": false,
"start_date": "2016-12-01",
"completion_date": "2023-10-06",
"has_results": true,
"results_due": true,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04204408",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04204408",
"title": "Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Subcutaneous Doses of NNC0365-3769 (Mim8) in Healthy Subjects and in Subjects With Haemophilia A With or Without Factor VIII Inhibitors",
"has_exemption": true,
"start_date": "2020-01-10",
"completion_date": "2023-10-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04387201",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04387201",
"title": "GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response",
"has_exemption": false,
"start_date": "2020-05-15",
"completion_date": "2023-10-06",
"has_results": true,
"results_due": true,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06424236",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06424236",
"title": "A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease",
"has_exemption": true,
"start_date": "2020-06-03",
"completion_date": "2023-10-06",
"has_results": true,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04734080",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04734080",
"title": "Effects of Perioperative Dronabinol Use in Total Knee Arthroplasty",
"has_exemption": false,
"start_date": "2021-03-01",
"completion_date": "2023-10-06",
"has_results": false,
"results_due": true,
"sponsor_name": "Hospital for Special Surgery, New York",
"sponsor_slug": "hospital-for-special-surgery-new-york",
"status": "overdue",
"is_pact": false,
"days_late": 316
},
{
"registry_id": "NCT04775953",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04775953",
"title": "Dalbavancin as an Option for Treatment of S. Aureus Bacteremia (DOTS): A Phase 2b, Multicenter, Randomized, Open-Label, Assessor-Blinded Superiority Study to Compare the Efficacy and Safety of Dalbavancin to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated S. Aureus Bacteremia",
"has_exemption": false,
"start_date": "2021-04-22",
"completion_date": "2023-10-06",
"has_results": true,
"results_due": true,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04886518",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04886518",
"title": "A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1, Followed by an Open-Label Extension",
"has_exemption": false,
"start_date": "2021-06-28",
"completion_date": "2023-10-06",
"has_results": true,
"results_due": true,
"sponsor_name": "Harmony Biosciences Management, Inc.",
"sponsor_slug": "harmony-biosciences-management-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04136626",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04136626",
"title": "Digital Health Interventions for Obsessive Compulsive Disorder: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2021-07-26",
"completion_date": "2023-10-06",
"has_results": true,
"results_due": true,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "reported-late",
"is_pact": false,
"days_late": 4
},
{
"registry_id": "NCT05061446",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05061446",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Week Dose-Ranging Study to Assess the Efficacy and Safety of Etrasimod in Japanese Participants With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2021-09-10",
"completion_date": "2023-10-06",
"has_results": true,
"results_due": true,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04983901",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04983901",
"title": "An Investigator Initiated, Phase II Single-Center, Randomized, Open-Label, Prospective, Study To Determine The Impact Of Serial Procalcitonin On Improving Antimicrobial Stewardship And On The Efficacy, Safety, And Tolerability Of Imipenem-Cilastatin-Relebactam Plus/Minus Vancomycin Or Linezolid Versus Standard Of Care Antipseudomonal Beta-Lactams Plus/Minus Vancomycin Or Linezolid As Empiric Therapy In Febrile Neutropenic Adults With Cancer",
"has_exemption": false,
"start_date": "2021-09-14",
"completion_date": "2023-10-06",
"has_results": true,
"results_due": true,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04826562",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04826562",
"title": "Switch to DOVATO in Patients Suppressed on Biktarvy (SOUND)",
"has_exemption": false,
"start_date": "2021-09-26",
"completion_date": "2023-10-06",
"has_results": false,
"results_due": true,
"sponsor_name": "Saint Michael's Medical Center",
"sponsor_slug": "saint-michaels-medical-center",
"status": "overdue",
"is_pact": false,
"days_late": 316
},
{
"registry_id": "NCT05255484",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05255484",
"title": "A Phase I/II, Open-Label, Dose Escalation and Expansion Study of LM-108 as a Single Agent or in Combination With Pembrolizumab in Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2022-05-26",
"completion_date": "2023-10-06",
"has_results": false,
"results_due": true,
"sponsor_name": "LaNova Medicines Limited",
"sponsor_slug": "lanova-medicines-limited",
"status": "overdue",
"is_pact": false,
"days_late": 316
},
{
"registry_id": "NCT05407064",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05407064",
"title": "A Phase 2, Multi-center, Randomized, Double-Blind, Parallel-Group, Dose-Finding Study to Assess the Effect of Four Doses of MM-120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms",
"has_exemption": false,
"start_date": "2022-08-24",
"completion_date": "2023-10-06",
"has_results": true,
"results_due": true,
"sponsor_name": "Mind Medicine, Inc.",
"sponsor_slug": "mind-medicine-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 45
},
{
"registry_id": "NCT05878067",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05878067",
"title": "A Patient Experience Study With ABBV-444 for Symptom Relief and Tolerability",
"has_exemption": false,
"start_date": "2023-06-27",
"completion_date": "2023-10-06",
"has_results": true,
"results_due": true,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04667468",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04667468",
"title": "Cold Stored Platelet Early Intervention in Hemorrhagic Shock (CriSP-HS) Trial",
"has_exemption": false,
"start_date": "2022-06-21",
"completion_date": "2023-10-07",
"has_results": true,
"results_due": true,
"sponsor_name": "Jason Sperry",
"sponsor_slug": "jason-sperry",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05495945",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05495945",
"title": "Ultrasonic Deep Brain Stimulation During Anesthetic Sedation",
"has_exemption": false,
"start_date": "2022-08-26",
"completion_date": "2023-10-07",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "reported-late",
"is_pact": false,
"days_late": 135
},
{
"registry_id": "NCT05679908",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05679908",
"title": "A Phase 2, Double-blind, Randomized, Multicenter, Placebo-controlled, Three Arm Parallel Study to Evaluate the Efficacy and Safety of TNX-1900 (Intranasal Oxytocin) in Patients With Chronic Migraine (PREVENTION Study)",
"has_exemption": false,
"start_date": "2022-12-06",
"completion_date": "2023-10-08",
"has_results": true,
"results_due": true,
"sponsor_name": "Tonix Pharmaceuticals, Inc.",
"sponsor_slug": "tonix-pharmaceuticals-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 119
},
{
"registry_id": "NCT02397720",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02397720",
"title": "An Open-Label Phase II Study of Nivolumab (BMS-936558) in Combination With 5-Azacytidine (Vidaza) or Nivolumab With Ipilimumab in Combination With 5-Azacytidine for the Treatment of Patients With Refractory/ Relapsed Acute Myeloid Leukemia and Newly Diagnosed Older AML (> 65 Years) Patients",
"has_exemption": false,
"start_date": "2015-04-07",
"completion_date": "2023-10-09",
"has_results": true,
"results_due": true,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02403323",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02403323",
"title": "An Open-Label Extension and Safety Monitoring Study of Patients With Moderately to Severely Active Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Protocol GA29144",
"has_exemption": false,
"start_date": "2015-06-08",
"completion_date": "2023-10-09",
"has_results": true,
"results_due": true,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03499236",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03499236",
"title": "RELIEVE-HF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure",
"has_exemption": false,
"start_date": "2018-09-19",
"completion_date": "2023-10-09",
"has_results": false,
"results_due": true,
"sponsor_name": "V-Wave Ltd",
"sponsor_slug": "v-wave-ltd",
"status": "overdue",
"is_pact": false,
"days_late": 313
},
{
"registry_id": "NCT03576885",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03576885",
"title": "Treatment of Delayed Pulmonary Transition in Extremely Preterm Infants & Bronchopulmonary Dysplasia",
"has_exemption": false,
"start_date": "2019-07-15",
"completion_date": "2023-10-09",
"has_results": true,
"results_due": true,
"sponsor_name": "AdventHealth",
"sponsor_slug": "adventhealth",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03878485",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03878485",
"title": "Pilot Study of Same-session MR-only Simulation and Treatment With Stereotactic MRI-guided Adaptive Radiotherapy (SMART) for Oligometastases of the Spine",
"has_exemption": true,
"start_date": "2019-11-06",
"completion_date": "2023-10-09",
"has_results": true,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04310397",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04310397",
"title": "Altering Adjuvant Therapy Based on Pathologic Response to Neoadjuvant Dabrafenib and Trametinib (ALTER-PATH NeoDT)",
"has_exemption": false,
"start_date": "2020-01-29",
"completion_date": "2023-10-09",
"has_results": true,
"results_due": true,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04687072",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04687072",
"title": "A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and the Safety of Efgartigimod (ARGX-113) PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia",
"has_exemption": false,
"start_date": "2020-12-16",
"completion_date": "2023-10-09",
"has_results": true,
"results_due": true,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03847311",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03847311",
"title": "Double Blind Trial Investigating the Role of Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients",
"has_exemption": false,
"start_date": "2021-05-03",
"completion_date": "2023-10-09",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "reported-late",
"is_pact": false,
"days_late": 42
},
{
"registry_id": "NCT05479058",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05479058",
"title": "A Randomized, Double-blind, Controlled, Multi-center Study to Evaluate the Efficacy and Safety of Dose De-escalation of Orally Administered Filgotinib in Subjects With Ulcerative Colitis in Clinical Remission",
"has_exemption": false,
"start_date": "2022-07-26",
"completion_date": "2023-10-09",
"has_results": true,
"results_due": true,
"sponsor_name": "Galapagos NV",
"sponsor_slug": "galapagos-nv",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03118232",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03118232",
"title": "Project PROTECT: Protecting Nursing Homes From Infections and Hospitalization",
"has_exemption": false,
"start_date": "2017-04-03",
"completion_date": "2023-10-10",
"has_results": true,
"results_due": true,
"sponsor_name": "University of California, Irvine",
"sponsor_slug": "university-of-california-irvine",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04010539",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04010539",
"title": "A Phase III, Randomized, Multicenter, Open-Label Study in Adolescent and Adult Participants Comparing the Efficacy and Safety of Gepotidacin to Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae",
"has_exemption": false,
"start_date": "2019-10-21",
"completion_date": "2023-10-10",
"has_results": true,
"results_due": true,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04305002",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04305002",
"title": "Effect of Exenatide on Disease Progression in Early Parkinson's Disease",
"has_exemption": false,
"start_date": "2020-01-21",
"completion_date": "2023-10-10",
"has_results": false,
"results_due": true,
"sponsor_name": "Center for Neurology, Stockholm",
"sponsor_slug": "center-for-neurology-stockholm",
"status": "overdue",
"is_pact": false,
"days_late": 312
},
{
"registry_id": "NCT04256824",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04256824",
"title": "Triclosan-antibacterial Sutures Efficacy on the Incidence of Surgical Site Infection in Clean-contaminated Wounds; Multi-center, Double Blind, Randomized Study",
"has_exemption": false,
"start_date": "2020-02-05",
"completion_date": "2023-10-10",
"has_results": false,
"results_due": true,
"sponsor_name": "ClinAmygate",
"sponsor_slug": "clinamygate",
"status": "overdue",
"is_pact": false,
"days_late": 312
},
{
"registry_id": "NCT04277546",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04277546",
"title": "A Phase 2 Open-label, Long-term Extension Safety Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis (EXPEDITION OLE)",
"has_exemption": false,
"start_date": "2020-03-03",
"completion_date": "2023-10-10",
"has_results": false,
"results_due": true,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04754399",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04754399",
"title": "Phase 2 Trial of Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias",
"has_exemption": false,
"start_date": "2021-04-16",
"completion_date": "2023-10-10",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05145192",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05145192",
"title": "Validity and Reliability of the K5 Wearable Metabolic System During High-Intensity Treadmill Testing in Healthy, Young Adults",
"has_exemption": false,
"start_date": "2021-11-29",
"completion_date": "2023-10-10",
"has_results": false,
"results_due": true,
"sponsor_name": "Baylor Research Institute",
"sponsor_slug": "baylor-research-institute",
"status": "overdue",
"is_pact": false,
"days_late": 312
},
{
"registry_id": "NCT05226286",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05226286",
"title": "Evaluation of Implantable Tibial Neuromodulation Pivotal Study",
"has_exemption": true,
"start_date": "2022-01-31",
"completion_date": "2023-10-10",
"has_results": false,
"results_due": false,
"sponsor_name": "MedtronicNeuro",
"sponsor_slug": "medtronicneuro",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05250102",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05250102",
"title": "Accuracy and Precision of Peripheral Capillary Oxygen Saturation of Reprocessed Pulse Oximetry Sensors Compared to Oxygen Saturation in Arterial Blood Samples Assessed by CO-oximetry in Neonates",
"has_exemption": false,
"start_date": "2022-06-13",
"completion_date": "2023-10-10",
"has_results": true,
"results_due": true,
"sponsor_name": "Medline Industries",
"sponsor_slug": "medline-industries",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05105035",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05105035",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Exploratory Study to Assess the Efficacy, Safety and Tolerability of Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Intensive Phase Therapy of Melioidosis in Hospitalized Patients",
"has_exemption": false,
"start_date": "2022-06-14",
"completion_date": "2023-10-10",
"has_results": false,
"results_due": true,
"sponsor_name": "Arrevus Inc.",
"sponsor_slug": "arrevus-inc",
"status": "overdue",
"is_pact": false,
"days_late": 312
},
{
"registry_id": "NCT05399355",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05399355",
"title": "Pulsed Electromagnetic Fields for Postoperative Analgesia: A Randomized, Triple-Masked, Sham-Controlled Pilot Study",
"has_exemption": false,
"start_date": "2022-07-18",
"completion_date": "2023-10-10",
"has_results": true,
"results_due": true,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05617911",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05617911",
"title": "Clinical Comparison of Patellofemoral Pain Syndrome Outcomes After Blood Flow Restriction Therapy",
"has_exemption": false,
"start_date": "2022-11-15",
"completion_date": "2023-10-10",
"has_results": false,
"results_due": true,
"sponsor_name": "Gaylord Hospital, Inc",
"sponsor_slug": "gaylord-hospital-inc",
"status": "overdue",
"is_pact": false,
"days_late": 312
},
{
"registry_id": "NCT06731569",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06731569",
"title": "Evaluation of the Lateral Window Approach of Maxillary Sinus Floor Augmentation Using a Newly Designed Advanced Intelligence Drill: a Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2022-12-03",
"completion_date": "2023-10-10",
"has_results": false,
"results_due": true,
"sponsor_name": "Beirut Arab University",
"sponsor_slug": "beirut-arab-university",
"status": "overdue",
"is_pact": false,
"days_late": 312
},
{
"registry_id": "NCT05653427",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05653427",
"title": "A Phase 2, Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Amivantamab Monotherapy in Participants With Previously Treated Advanced Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2022-12-08",
"completion_date": "2023-10-10",
"has_results": true,
"results_due": true,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03181516",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03181516",
"title": "Efficacy and Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Children on Antibiotics",
"has_exemption": false,
"start_date": "2017-09-30",
"completion_date": "2023-10-11",
"has_results": true,
"results_due": true,
"sponsor_name": "Georgetown University",
"sponsor_slug": "georgetown-university",
"status": "reported-late",
"is_pact": false,
"days_late": 61
},
{
"registry_id": "NCT03150173",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03150173",
"title": "Buprenorphine Treatment at Syringe Exchanges to Reduce Opioid Misuse and HIV Risk",
"has_exemption": false,
"start_date": "2019-01-02",
"completion_date": "2023-10-11",
"has_results": true,
"results_due": true,
"sponsor_name": "Montefiore Medical Center",
"sponsor_slug": "montefiore-medical-center",
"status": "reported-late",
"is_pact": false,
"days_late": 68
},
{
"registry_id": "NCT03776136",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03776136",
"title": "A Multicenter, Open-label, Phase 2 Trial to Assess the Efficacy and Safety of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Melanoma Previously Exposed to an Anti-PD-1/L1 Agent (LEAP-004)",
"has_exemption": false,
"start_date": "2019-01-30",
"completion_date": "2023-10-11",
"has_results": true,
"results_due": true,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04432831",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04432831",
"title": "A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Patients With Diabetic Macular Edema",
"has_exemption": false,
"start_date": "2020-08-05",
"completion_date": "2023-10-11",
"has_results": true,
"results_due": true,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04399369",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04399369",
"title": "Preventing Early Childhood Caries with Silver Diamine Fluoride - a 12-month Randomised Clinical Trial",
"has_exemption": false,
"start_date": "2020-10-22",
"completion_date": "2023-10-11",
"has_results": false,
"results_due": true,
"sponsor_name": "The University of Hong Kong",
"sponsor_slug": "the-university-of-hong-kong",
"status": "overdue",
"is_pact": false,
"days_late": 311
},
{
"registry_id": "NCT04723147",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04723147",
"title": "Dopaminergic Therapy for Inflammation-Related Anhedonia in Depression",
"has_exemption": false,
"start_date": "2021-01-29",
"completion_date": "2023-10-11",
"has_results": true,
"results_due": true,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04676087",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04676087",
"title": "Mogamulizumab and Extracorporeal Photopheresis (ECP) for the Treatment of Sézary Syndrome and Erythrodermic Mycosis Fungoides, a Phase 1b/2 Study",
"has_exemption": false,
"start_date": "2021-04-21",
"completion_date": "2023-10-11",
"has_results": false,
"results_due": true,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "overdue",
"is_pact": false,
"days_late": 311
},
{
"registry_id": "NCT05000450",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05000450",
"title": "A Single-Arm, Open-Label, Phase 1/2 Study Evaluating the Safety, Efficacy, and Cellular Kinetics/Pharmacodynamics of ALLO-647 and ALLO-605, an Anti- BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2021-06-06",
"completion_date": "2023-10-11",
"has_results": false,
"results_due": true,
"sponsor_name": "Allogene Therapeutics",
"sponsor_slug": "allogene-therapeutics",
"status": "overdue",
"is_pact": false,
"days_late": 311
},
{
"registry_id": "NCT04916470",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04916470",
"title": "Effect of Semaglutide 2.4 mg Once-weekly on Function and Symptoms in Subjects With Obesity-related Heart Failure With Preserved Ejection Fraction, and Type 2 Diabetes",
"has_exemption": true,
"start_date": "2021-06-15",
"completion_date": "2023-10-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05008224",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05008224",
"title": "Phase 2 Study of Pembrolizumab and Chemotherapy in Patients With Newly Diagnosed Classical Hodgkin Lymphoma (KEYNOTE-C11)",
"has_exemption": false,
"start_date": "2021-10-07",
"completion_date": "2023-10-11",
"has_results": true,
"results_due": true,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05310422",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05310422",
"title": "Safety Study of Tivanisiran to Treat Dry Eye",
"has_exemption": false,
"start_date": "2022-03-24",
"completion_date": "2023-10-11",
"has_results": false,
"results_due": true,
"sponsor_name": "Sylentis, S.A.",
"sponsor_slug": "sylentis-sa",
"status": "overdue",
"is_pact": false,
"days_late": 311
},
{
"registry_id": "NCT05261490",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05261490",
"title": "A Phase Ⅰ/Ⅱ Study of TTI-622 in Combination With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer",
"has_exemption": false,
"start_date": "2022-08-01",
"completion_date": "2023-10-11",
"has_results": true,
"results_due": true,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05646719",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05646719",
"title": "Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 3 Study of the Safety and Efficacy of Nyxol (Phentolamine Ophthalmic Solution 0.75%) as a Single Agent and With Adjunctive Low-Dose Pilocarpine Hydrochloride Ophthalmic Solution 0.4% in Subjects With Presbyopia",
"has_exemption": false,
"start_date": "2022-12-22",
"completion_date": "2023-10-11",
"has_results": true,
"results_due": true,
"sponsor_name": "Ocuphire Pharma, Inc.",
"sponsor_slug": "ocuphire-pharma-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 203
},
{
"registry_id": "NCT02035787",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02035787",
"title": "Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients",
"has_exemption": false,
"start_date": "2014-02-27",
"completion_date": "2023-10-12",
"has_results": true,
"results_due": true,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03761056",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03761056",
"title": "A Phase 2 Multicenter Study Evaluating the Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Subjects With High-Risk Large B-Cell Lymphoma (ZUMA-12)",
"has_exemption": false,
"start_date": "2019-01-29",
"completion_date": "2023-10-12",
"has_results": true,
"results_due": true,
"sponsor_name": "Kite, A Gilead Company",
"sponsor_slug": "kite-a-gilead-company",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03677141",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03677141",
"title": "A Phase Ib/II, Open-Label, Multicenter, Randomized, Controlled Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Patients With B-Cell Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2019-03-08",
"completion_date": "2023-10-12",
"has_results": true,
"results_due": true,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "reported-late",
"is_pact": false,
"days_late": 2
},
{
"registry_id": "NCT03798691",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03798691",
"title": "A Pilot Study Evaluating Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab",
"has_exemption": true,
"start_date": "2019-05-28",
"completion_date": "2023-10-12",
"has_results": true,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04105010",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04105010",
"title": "A Phase I/II, Open-Label, Multicentre Study to Investigate the Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD4205 in Patients With Peripheral T Cell Lymphoma (PTCL)",
"has_exemption": false,
"start_date": "2019-09-10",
"completion_date": "2023-10-12",
"has_results": true,
"results_due": true,
"sponsor_name": "Dizal Pharmaceuticals",
"sponsor_slug": "dizal-pharmaceuticals",
"status": "reported-late",
"is_pact": false,
"days_late": 100
},
{
"registry_id": "NCT05103657",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05103657",
"title": "A Phase II, 8-week-treatment, Multicenter, Randomized, Doubleblind, Placebo-controlled, Parallel Group Trial to Evaluate the Efficacy, Tolerability and Safety of Orally Administered BI 1358894 in Patients With Post-Traumatic Stress Disorder (PTSD)",
"has_exemption": false,
"start_date": "2021-12-07",
"completion_date": "2023-10-12",
"has_results": true,
"results_due": true,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05072964",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05072964",
"title": "The FARAPULSE FARA-Freedom Trial A Prospective Open Label Single Arm Post Market Clinical Follow-Up Trial of the FARAPULSE Pulsed Field Ablation System in Patients With Paroxysmal Atrial Fibrillation",
"has_exemption": false,
"start_date": "2021-12-21",
"completion_date": "2023-10-12",
"has_results": true,
"results_due": true,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05231278",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05231278",
"title": "Needle-Based Confocal Laser Endomicroscopy to Aid in Lung Nodule Localization by Robotic-Assisted Navigational Bronchoscopy",
"has_exemption": false,
"start_date": "2022-01-20",
"completion_date": "2023-10-12",
"has_results": false,
"results_due": true,
"sponsor_name": "Johnson & Johnson Enterprise Innovation Inc.",
"sponsor_slug": "johnson-johnson-enterprise-innovation-inc",
"status": "overdue",
"is_pact": false,
"days_late": 310
},
{
"registry_id": "NCT05486065",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05486065",
"title": "Investigation of Once-weekly Semaglutide S.C. Dose-Response in Patients With Type 2 Diabetes and Overweight - a Participant- and Investigator-blinded and Sponsor Open-label Study",
"has_exemption": false,
"start_date": "2022-08-08",
"completion_date": "2023-10-12",
"has_results": true,
"results_due": true,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05512949",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05512949",
"title": "A Phase 2 Randomized, Open-Label, Multisite Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Vaccine",
"has_exemption": true,
"start_date": "2022-09-09",
"completion_date": "2023-10-12",
"has_results": true,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05406596",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05406596",
"title": "LiquID Guide Catheter Extension Safety Study",
"has_exemption": false,
"start_date": "2022-10-13",
"completion_date": "2023-10-12",
"has_results": true,
"results_due": true,
"sponsor_name": "Seigla Medical, Inc.",
"sponsor_slug": "seigla-medical-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05552430",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05552430",
"title": "Physical and Psychological Measures of Pain in Acute Orthopedic Injuries: Use of At-home Virtual Reality",
"has_exemption": false,
"start_date": "2022-10-17",
"completion_date": "2023-10-12",
"has_results": true,
"results_due": true,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05660538",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05660538",
"title": "A Phase 2, Randomized, Double-blind, Active-controlled, Dose-ranging, Parallel-design Study of the Efficacy and Safety of VX-548 in Subjects With Painful Diabetic Peripheral Neuropathy",
"has_exemption": true,
"start_date": "2022-12-20",
"completion_date": "2023-10-12",
"has_results": true,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02218606",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02218606",
"title": "An Exploratory Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2014-08-31",
"completion_date": "2023-10-13",
"has_results": true,
"results_due": true,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02598661",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02598661",
"title": "A Study to Evaluate Imetelstat (GRN163L) in Transfusion-Dependent Subjects With IPSS Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) That is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment",
"has_exemption": false,
"start_date": "2016-01-12",
"completion_date": "2023-10-13",
"has_results": true,
"results_due": true,
"sponsor_name": "Geron Corporation",
"sponsor_slug": "geron-corporation",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03163511",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03163511",
"title": "An Open-Label, First-In-Human Study Evaluating the Safety, Tolerability, and Efficacy of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness",
"has_exemption": false,
"start_date": "2017-07-06",
"completion_date": "2023-10-13",
"has_results": true,
"results_due": true,
"sponsor_name": "ViaCyte",
"sponsor_slug": "viacyte",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03285321",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03285321",
"title": "Phase II Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC): BTCRC-LUN16-081",
"has_exemption": false,
"start_date": "2017-09-15",
"completion_date": "2023-10-13",
"has_results": true,
"results_due": true,
"sponsor_name": "Greg Durm, MD",
"sponsor_slug": "greg-durm-md",
"status": "reported-late",
"is_pact": false,
"days_late": 93
},
{
"registry_id": "NCT03978637",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03978637",
"title": "An Open-Label, Single-Arm, Phase 1/2 Study Evaluating the Safety and Efficacy of Itacitinib in Participants With Bronchiolitis Obliterans Syndrome Following Lung Transplantation",
"has_exemption": false,
"start_date": "2020-02-04",
"completion_date": "2023-10-13",
"has_results": true,
"results_due": true,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04187833",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04187833",
"title": "Phase II Trial of Nivolumab in Combination With Talazoparib in Patients With Unresectable or Metastatic Melanoma and Mutations in BRCA or BRCA-ness Genes",
"has_exemption": false,
"start_date": "2020-06-05",
"completion_date": "2023-10-13",
"has_results": true,
"results_due": true,
"sponsor_name": "Case Comprehensive Cancer Center",
"sponsor_slug": "case-comprehensive-cancer-center",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05020392",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05020392",
"title": "Efficacy and Safety of Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell Lymphoma：a Single-center, Open-label, Pragmatic Clinical Trial",
"has_exemption": false,
"start_date": "2021-09-14",
"completion_date": "2023-10-13",
"has_results": false,
"results_due": true,
"sponsor_name": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",
"sponsor_slug": "union-hospital-tongji-medical-college-huazhong-university-of-science-and-technology",
"status": "overdue",
"is_pact": false,
"days_late": 309
},
{
"registry_id": "NCT05444543",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05444543",
"title": "Effectiveness of Cycling of Topical Steroid Therapy in Maintaining Clinical and Histologic Remission in Eosinophilic Esophagitis",
"has_exemption": false,
"start_date": "2021-11-17",
"completion_date": "2023-10-13",
"has_results": true,
"results_due": true,
"sponsor_name": "University Hospitals Cleveland Medical Center",
"sponsor_slug": "university-hospitals-cleveland-medical-center",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03878316",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03878316",
"title": "Randomized, Double Blind, Placebo-Controlled Trial of the Efficacy of Intranasal Oxytocin for the Treatment of Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2022-06-29",
"completion_date": "2023-10-13",
"has_results": true,
"results_due": true,
"sponsor_name": "National Institute on Alcohol Abuse and Alcoholism (NIAAA)",
"sponsor_slug": "national-institute-on-alcohol-abuse-and-alcoholism-niaaa",
"status": "reported-late",
"is_pact": false,
"days_late": 246
},
{
"registry_id": "NCT05587322",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05587322",
"title": "A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease",
"has_exemption": false,
"start_date": "2022-09-06",
"completion_date": "2023-10-13",
"has_results": false,
"results_due": true,
"sponsor_name": "Braintree Laboratories",
"sponsor_slug": "braintree-laboratories",
"status": "overdue",
"is_pact": false,
"days_late": 309
},
{
"registry_id": "NCT05548491",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05548491",
"title": "A Two Stage, Multi-center, Vehicle-controlled, Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AZR-MD-001 and to Determine Common Symptoms in Contact Lens Discomfort (CLD)",
"has_exemption": false,
"start_date": "2022-11-10",
"completion_date": "2023-10-13",
"has_results": false,
"results_due": true,
"sponsor_name": "Azura Ophthalmics",
"sponsor_slug": "azura-ophthalmics",
"status": "reported-late",
"is_pact": false,
"days_late": 107
},
{
"registry_id": "NCT04889664",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04889664",
"title": "Adding Trauma-focused Psychotherapy to Ketamine Treatment for Chronic PTSD: A Pilot Study",
"has_exemption": false,
"start_date": "2021-06-04",
"completion_date": "2023-10-14",
"has_results": true,
"results_due": true,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02572323",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02572323",
"title": "Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons",
"has_exemption": false,
"start_date": "2017-02-15",
"completion_date": "2023-10-15",
"has_results": false,
"results_due": true,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05012397",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05012397",
"title": "A Phase 2 Basket Study of Milademetan in Advanced/Metastatic Solid Tumors (MANTRA-2)",
"has_exemption": false,
"start_date": "2021-11-01",
"completion_date": "2023-10-15",
"has_results": true,
"results_due": true,
"sponsor_name": "Rain Oncology Inc",
"sponsor_slug": "rain-oncology-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05486520",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05486520",
"title": "A New Breast Cancer MRI Biomarker Using the Intrinsic T1rho Signal",
"has_exemption": false,
"start_date": "2022-09-01",
"completion_date": "2023-10-15",
"has_results": false,
"results_due": true,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "overdue",
"is_pact": false,
"days_late": 307
},
{
"registry_id": "NCT04951492",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04951492",
"title": "Olaparib in Prostate Cancer Patients With Evidence of Homologous Recombination Deficiency as Assessed Using an Integrated Genomic Signature",
"has_exemption": false,
"start_date": "2022-11-09",
"completion_date": "2023-10-15",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03608033",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03608033",
"title": "A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy (ARTEMIS - IGAN)",
"has_exemption": false,
"start_date": "2018-02-16",
"completion_date": "2023-10-16",
"has_results": false,
"results_due": true,
"sponsor_name": "Omeros Corporation",
"sponsor_slug": "omeros-corporation",
"status": "reported-late",
"is_pact": false,
"days_late": 86
},
{
"registry_id": "NCT03414034",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03414034",
"title": "A Phase 2 Study of PCM-075 (Onvansertib) in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2018-08-14",
"completion_date": "2023-10-16",
"has_results": true,
"results_due": true,
"sponsor_name": "Cardiff Oncology",
"sponsor_slug": "cardiff-oncology",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04243551",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04243551",
"title": "Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of Latiglutenase Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet While Undergoing Periodic Gluten Exposure",
"has_exemption": false,
"start_date": "2019-11-01",
"completion_date": "2023-10-16",
"has_results": false,
"results_due": true,
"sponsor_name": "Entero Therapeutics",
"sponsor_slug": "entero-therapeutics",
"status": "overdue",
"is_pact": false,
"days_late": 306
},
{
"registry_id": "NCT04409288",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04409288",
"title": "Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer: An Open-label, Randomized, Cross-Over Trial.",
"has_exemption": false,
"start_date": "2020-07-20",
"completion_date": "2023-10-16",
"has_results": false,
"results_due": true,
"sponsor_name": "Chinese University of Hong Kong",
"sponsor_slug": "chinese-university-of-hong-kong",
"status": "overdue",
"is_pact": false,
"days_late": 306
},
{
"registry_id": "NCT04547985",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04547985",
"title": "Naltrexone Treatment for Prolonged Grief Disorder: A Pilot Study",
"has_exemption": false,
"start_date": "2021-01-05",
"completion_date": "2023-10-16",
"has_results": true,
"results_due": true,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04814186",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04814186",
"title": "A Study to Characterize the Safety and Efficacy of Tafamidis Once Daily in the Treatment of Transthyretin Amyloid Cardiomyopathy in Chinese Participants",
"has_exemption": false,
"start_date": "2021-07-22",
"completion_date": "2023-10-16",
"has_results": true,
"results_due": true,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04763564",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04763564",
"title": "Efficacy of Liraglutide Therapy in Patients With an Ileal -Pouch Anal Anastomosis (IPAA) and Chronic High Bowel Frequency",
"has_exemption": false,
"start_date": "2022-03-22",
"completion_date": "2023-10-16",
"has_results": true,
"results_due": true,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05385783",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05385783",
"title": "A Phase I/IIa, Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Relative Bioavailability and Food Effect Cohort to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of CYB003 in Healthy Participants With and Without Major Depressive Disorder (MDD)",
"has_exemption": false,
"start_date": "2022-08-02",
"completion_date": "2023-10-16",
"has_results": false,
"results_due": true,
"sponsor_name": "Cybin IRL Limited",
"sponsor_slug": "cybin-irl-limited",
"status": "reported-late",
"is_pact": false,
"days_late": 230
},
{
"registry_id": "NCT05481125",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05481125",
"title": "Clareon Toric vs Eyhance Toric",
"has_exemption": false,
"start_date": "2022-10-10",
"completion_date": "2023-10-16",
"has_results": true,
"results_due": true,
"sponsor_name": "Alcon Research",
"sponsor_slug": "alcon-research",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05618912",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05618912",
"title": "Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2022-10-17",
"completion_date": "2023-10-16",
"has_results": true,
"results_due": true,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03901534",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03901534",
"title": "Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD",
"has_exemption": false,
"start_date": "2023-01-01",
"completion_date": "2023-10-16",
"has_results": true,
"results_due": true,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "reported-late",
"is_pact": false,
"days_late": 29
},
{
"registry_id": "NCT05626803",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05626803",
"title": "A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Single Dose, Dose-ranging Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccine Administered Orally to Healthy Volunteers Aged Greater Than or Equal to 18 Years and Less Than or Equal to 80 Years Old.",
"has_exemption": false,
"start_date": "2023-01-26",
"completion_date": "2023-10-16",
"has_results": true,
"results_due": true,
"sponsor_name": "Vaxart",
"sponsor_slug": "vaxart",
"status": "reported-late",
"is_pact": false,
"days_late": 132
},
{
"registry_id": "NCT05765253",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05765253",
"title": "A Prospective, Multicenter, Randomized Study Evaluating Portal Vein Access Sets During Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedures",
"has_exemption": false,
"start_date": "2023-07-13",
"completion_date": "2023-10-16",
"has_results": true,
"results_due": true,
"sponsor_name": "Argon Medical Devices",
"sponsor_slug": "argon-medical-devices",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04871074",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04871074",
"title": "SV2A PET Imaging in Alzheimer's Disease",
"has_exemption": true,
"start_date": "2018-11-18",
"completion_date": "2023-10-17",
"has_results": true,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03878979",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03878979",
"title": "Preoperative Immune Checkpoint Inhibitor Therapy for Patients With Primary Untreated or Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (RM-SCCHN)",
"has_exemption": false,
"start_date": "2019-07-08",
"completion_date": "2023-10-17",
"has_results": true,
"results_due": true,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03836209",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03836209",
"title": "Randomized Trial of Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia (AML)",
"has_exemption": false,
"start_date": "2019-12-06",
"completion_date": "2023-10-17",
"has_results": true,
"results_due": true,
"sponsor_name": "PrECOG, LLC.",
"sponsor_slug": "precog-llc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04409353",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04409353",
"title": "Randomized-controlled Trial of Virtual Reality for Chronic Low Back Pain to Improve Patient-reported Outcomes and Physical Activity",
"has_exemption": false,
"start_date": "2020-10-21",
"completion_date": "2023-10-17",
"has_results": true,
"results_due": true,
"sponsor_name": "Cedars-Sinai Medical Center",
"sponsor_slug": "cedars-sinai-medical-center",
"status": "reported-late",
"is_pact": false,
"days_late": 49
},
{
"registry_id": "NCT04866017",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04866017",
"title": "A Phase 3, Randomized, Open-Label Study to Compare Ociperlimab (BGB-A1217) Plus Tislelizumab (BGB-A317) Versus Durvalumab in Patients With Locally Advanced, Unresectable, PD-L1-Selected Non-Small Cell Lung Cancer Whose Disease Has Not Progressed After Concurrent Chemoradiotherapy",
"has_exemption": false,
"start_date": "2021-06-17",
"completion_date": "2023-10-17",
"has_results": true,
"results_due": true,
"sponsor_name": "BeiGene",
"sponsor_slug": "beigene",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05073458",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05073458",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic Anemia",
"has_exemption": false,
"start_date": "2022-03-15",
"completion_date": "2023-10-17",
"has_results": true,
"results_due": true,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05360966",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05360966",
"title": "A Phase 3 Study Evaluating the Safety and Efficacy of AR-15512, a Cold Thermoreceptor Modulator, for the Treatment of Dry Eye Disease (COMET-3)",
"has_exemption": true,
"start_date": "2022-07-18",
"completion_date": "2023-10-17",
"has_results": true,
"results_due": false,
"sponsor_name": "Aerie Pharmaceuticals",
"sponsor_slug": "aerie-pharmaceuticals",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05903495",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05903495",
"title": "A Randomized, Sham-Controlled Trial Investigating Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder",
"has_exemption": false,
"start_date": "2023-07-01",
"completion_date": "2023-10-17",
"has_results": false,
"results_due": true,
"sponsor_name": "West Virginia University",
"sponsor_slug": "west-virginia-university",
"status": "overdue",
"is_pact": false,
"days_late": 305
},
{
"registry_id": "NCT01563341",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01563341",
"title": "Tandem DBS for Parkinson's Disease: A Pilot Study Utilizing STN/GPi + Hypothalamic Stimulation",
"has_exemption": false,
"start_date": "2012-04-30",
"completion_date": "2023-10-18",
"has_results": true,
"results_due": true,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01595321",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01595321",
"title": "Pilot Study Evaluating Allogeneic GM-CSF-Transduced Pancreatic Tumor Cell Vaccine (GVAX) and Low Dose Cyclophosphamide With Fractionated Stereotactic Body Radiation Therapy (SBRT) and FOLFIRINOX Chemotherapy in Patients With Resected Adenocarcinoma of the Pancreas",
"has_exemption": false,
"start_date": "2012-10-29",
"completion_date": "2023-10-18",
"has_results": true,
"results_due": true,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02760498",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02760498",
"title": "A Phase 2 Study of REGN2810, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients With Advanced Cutaneous Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2016-04-07",
"completion_date": "2023-10-18",
"has_results": true,
"results_due": true,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03153982",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03153982",
"title": "Pharmacodynamic Effects and Predictive Biomarkers of Janus Kinases (JAK)/Signal Transducer and Activator of Transcription (STAT) Inhibition With Ruxolitinib in Operable Head and Neck Cancer: a Window Trial",
"has_exemption": false,
"start_date": "2018-06-08",
"completion_date": "2023-10-18",
"has_results": true,
"results_due": true,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03759288",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03759288",
"title": "A 52-Week, Multicenter, Randomized, Double-blind, Placebo and Active-Controlled, Operationally Seamless Phase 2b/3, Parallel-group Study to Assess the Efficacy and Safety of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease (INTREPID Lead-In)",
"has_exemption": false,
"start_date": "2018-12-07",
"completion_date": "2023-10-18",
"has_results": false,
"results_due": true,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04238793",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04238793",
"title": "A Phase 1/2a, First-in-Human, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Therapeutic Activity of Single Ascending Doses of KLS-2031 Administered by Transforaminal Epidural Injection in Patients With Neuropathic Pain From Lumbosacral Radiculopathy",
"has_exemption": false,
"start_date": "2020-04-16",
"completion_date": "2023-10-18",
"has_results": false,
"results_due": true,
"sponsor_name": "Kolon Life Science",
"sponsor_slug": "kolon-life-science",
"status": "overdue",
"is_pact": false,
"days_late": 304
},
{
"registry_id": "NCT05006261",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05006261",
"title": "A Mobile Tai Chi Platform for Fall Prevention in Older Adults - Phase II",
"has_exemption": false,
"start_date": "2021-09-29",
"completion_date": "2023-10-18",
"has_results": true,
"results_due": true,
"sponsor_name": "Spaulding Rehabilitation Hospital",
"sponsor_slug": "spaulding-rehabilitation-hospital",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05169710",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05169710",
"title": "A Multi-region, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating SEP-4199 Controlled Release (CR) for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression)",
"has_exemption": false,
"start_date": "2021-12-21",
"completion_date": "2023-10-18",
"has_results": true,
"results_due": true,
"sponsor_name": "Sumitomo Pharma America, Inc.",
"sponsor_slug": "sumitomo-pharma-america-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05291689",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05291689",
"title": "A Phase 2a, Open-label, Single-arm Study to Evaluate the Efficacy, Safety, and Tolerability of MORF-057 in Adults With Moderately to Severely Active Ulcerative Colitis (EMERALD-1)",
"has_exemption": false,
"start_date": "2022-05-24",
"completion_date": "2023-10-18",
"has_results": true,
"results_due": true,
"sponsor_name": "Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)",
"sponsor_slug": "morphic-therapeutic-inc-a-wholly-owned-subsidiary-of-eli-lilly-and-company",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06103695",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06103695",
"title": "Open Label, Observational Study, Evaluating VTAMA® (Tapinarof) Cream, 1% QD in Psoriasis Patients Being Treated With Biologic Agents.",
"has_exemption": false,
"start_date": "2023-02-27",
"completion_date": "2023-10-18",
"has_results": false,
"results_due": true,
"sponsor_name": "Psoriasis Treatment Center of Central New Jersey",
"sponsor_slug": "psoriasis-treatment-center-of-central-new-jersey",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02506192",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02506192",
"title": "Gulf War Illness Inflammation Reduction Trial",
"has_exemption": false,
"start_date": "2015-07-31",
"completion_date": "2023-10-19",
"has_results": true,
"results_due": true,
"sponsor_name": "Minneapolis Veterans Affairs Medical Center",
"sponsor_slug": "minneapolis-veterans-affairs-medical-center",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02761057",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02761057",
"title": "A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib [NSC #761968], Crizotinib [NSC #749005], Savolitinib [NSC #785348], and Sunitinib [NSC #736511]) in Metastatic Papillary Renal Carcinoma (PAPMET)",
"has_exemption": false,
"start_date": "2016-07-25",
"completion_date": "2023-10-19",
"has_results": true,
"results_due": true,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03287817",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03287817",
"title": "A Single Arm, Open-label, Multi-centre, Phase I/II Study Evaluating the Safety and Clinical Activity of AUTO3, a CAR T Cell Treatment Targeting CD19 and CD22 With Anti Programmed Cell Death Protein 1 (PD1) Antibody in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma",
"has_exemption": false,
"start_date": "2017-09-05",
"completion_date": "2023-10-19",
"has_results": true,
"results_due": true,
"sponsor_name": "Autolus Limited",
"sponsor_slug": "autolus-limited",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03395184",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03395184",
"title": "A PHASE 2A, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL PF-06651600 AND PF-06700841 AS INDUCTION AND OPEN LABEL EXTENSION TREATMENT IN SUBJECTS WITH MODERATE TO SEVERE CROHN'S DISEASE",
"has_exemption": false,
"start_date": "2018-02-02",
"completion_date": "2023-10-19",
"has_results": true,
"results_due": true,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03733691",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03733691",
"title": "A Phase 2, Open Label, Randomized Trial Evaluating Ixazomib Compared to Ixazomib-Lenalidomide Combination Maintenance Therapy for Frontline Multiple Myeloma Patients",
"has_exemption": false,
"start_date": "2019-03-01",
"completion_date": "2023-10-19",
"has_results": false,
"results_due": true,
"sponsor_name": "Oncotherapeutics",
"sponsor_slug": "oncotherapeutics",
"status": "overdue",
"is_pact": false,
"days_late": 303
},
{
"registry_id": "NCT03872388",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03872388",
"title": "Atorvastatin in Triple-Negative Breast Cancer (TNBC) Patients Who Did Not Achieve a Pathologic Complete Response (pCR) After Receiving Neoadjuvant Chemotherapy, a Multicenter Pilot Study",
"has_exemption": false,
"start_date": "2019-09-23",
"completion_date": "2023-10-19",
"has_results": true,
"results_due": true,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04060199",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04060199",
"title": "A Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With Duchenne Muscular Dystrophy (DMD)",
"has_exemption": false,
"start_date": "2020-04-14",
"completion_date": "2023-10-19",
"has_results": true,
"results_due": true,
"sponsor_name": "NS Pharma, Inc.",
"sponsor_slug": "ns-pharma-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04535544",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04535544",
"title": "A Phase 2, Multicenter, Randomized, Double-blind, Placebo-Controlled Study With Deferred Active Treatment to Investigate the Efficacy, Safety, and Pharmacokinetics of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus",
"has_exemption": false,
"start_date": "2020-09-17",
"completion_date": "2023-10-19",
"has_results": true,
"results_due": true,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05030012",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05030012",
"title": "Maintaining Optimal Delivery Using Automatic Titration of Oxygen in Preterm Infants Receiving High Velocity Nasal Insufflation Therapy",
"has_exemption": false,
"start_date": "2021-09-02",
"completion_date": "2023-10-19",
"has_results": true,
"results_due": true,
"sponsor_name": "Vapotherm, Inc.",
"sponsor_slug": "vapotherm-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05037851",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05037851",
"title": "A Randomized Controlled Open-label Study to Assess the Safety and Tolerability of Nebulized PC945 for Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients (OPERA-S Study)",
"has_exemption": true,
"start_date": "2021-11-19",
"completion_date": "2023-10-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Pulmocide Ltd",
"sponsor_slug": "pulmocide-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05194124",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05194124",
"title": "A Phase 3, Randomized, Double-Blind Trial of Two Formulations of Setmelanotide (Daily and Weekly) With a Crossover to Open-Label Once Weekly Setmelanotide in Patients With Specific Gene Defects in the Melanocortin-4 Receptor Pathway Who Are Currently on a Stable Dose of the Once Daily Formulation",
"has_exemption": false,
"start_date": "2021-12-21",
"completion_date": "2023-10-19",
"has_results": true,
"results_due": true,
"sponsor_name": "Rhythm Pharmaceuticals, Inc.",
"sponsor_slug": "rhythm-pharmaceuticals-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05065411",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05065411",
"title": "P3 Efficacy Evaluation of Enobosarm in Combo With Abemaciclib Compared to Estrogen Blocking Agent for 2nd Line Treatment of ER+HER2- MBC in Patients Who Have Shown Previous Disease Progression on an Estrogen Blocking Agent Plus Palbociclib",
"has_exemption": false,
"start_date": "2022-04-11",
"completion_date": "2023-10-19",
"has_results": false,
"results_due": true,
"sponsor_name": "Veru Inc.",
"sponsor_slug": "veru-inc",
"status": "overdue",
"is_pact": false,
"days_late": 303
},
{
"registry_id": "NCT05330312",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05330312",
"title": "A Randomized, Controlled, Parallel-group Clinical Investigation Evaluating the Impact of Digital Cognitive Behavioural Therapy on Psychological Symptom Burden in Adults Diagnosed With Pulmonary Fibrosis",
"has_exemption": false,
"start_date": "2022-04-17",
"completion_date": "2023-10-19",
"has_results": true,
"results_due": true,
"sponsor_name": "Vicore Pharma AB",
"sponsor_slug": "vicore-pharma-ab",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05635838",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05635838",
"title": "A Phase 2, Double-Blind, Randomized, Vehicle-Controlled, Efficacy, and Safety Study of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa",
"has_exemption": false,
"start_date": "2022-12-07",
"completion_date": "2023-10-19",
"has_results": true,
"results_due": true,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05773053",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05773053",
"title": "A Prospective, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of NT 201 Doses in the Treatment of Platysma Prominence",
"has_exemption": true,
"start_date": "2023-03-22",
"completion_date": "2023-10-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Merz Aesthetics GmbH",
"sponsor_slug": "merz-aesthetics-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05556967",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05556967",
"title": "Identification of Surrogate Blood and/or Urine Biomarker for Immulina TM in Normal Humans",
"has_exemption": false,
"start_date": "2023-08-09",
"completion_date": "2023-10-19",
"has_results": false,
"results_due": true,
"sponsor_name": "University of Mississippi Medical Center",
"sponsor_slug": "university-of-mississippi-medical-center",
"status": "overdue",
"is_pact": false,
"days_late": 303
},
{
"registry_id": "NCT03466411",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03466411",
"title": "A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease",
"has_exemption": true,
"start_date": "2018-04-13",
"completion_date": "2023-10-20",
"has_results": true,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03691610",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03691610",
"title": "Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers",
"has_exemption": false,
"start_date": "2018-10-04",
"completion_date": "2023-10-20",
"has_results": true,
"results_due": true,
"sponsor_name": "Sanofi Pasteur, a Sanofi Company",
"sponsor_slug": "sanofi-pasteur-a-sanofi-company",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03901339",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03901339",
"title": "Phase 3 Study of Sacituzumab Govitecan (IMMU-132) Versus Treatment of Physician's Choice (TPC) in Subjects With Hormonal Receptor-Positive (HR+) Human Epidermal Growth Factor Receptor 2 (HER2) Negative Metastatic Breast Cancer (MBC) Who Have Failed at Least Two Prior Chemotherapy Regimens",
"has_exemption": false,
"start_date": "2019-05-08",
"completion_date": "2023-10-20",
"has_results": true,
"results_due": true,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03840486",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03840486",
"title": "Real Time Assessment of Pre-oxygenation Utilizing End-tidal Oxygen Measurements Versus Single Breath End-Tidal Oxygen Measurements in Healthy Volunteers",
"has_exemption": false,
"start_date": "2019-09-24",
"completion_date": "2023-10-20",
"has_results": true,
"results_due": true,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "reported-late",
"is_pact": false,
"days_late": 1
},
{
"registry_id": "NCT04732429",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04732429",
"title": "A Phase 2 Open-label, Dose Escalation Study of HST5040 in Subjects With Propionic or Methylmalonic Acidemia Followed by a Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study and an Open-label, Long-term Extension Study",
"has_exemption": false,
"start_date": "2021-03-15",
"completion_date": "2023-10-20",
"has_results": false,
"results_due": true,
"sponsor_name": "HemoShear Therapeutics",
"sponsor_slug": "hemoshear-therapeutics",
"status": "overdue",
"is_pact": false,
"days_late": 302
},
{
"registry_id": "NCT04706091",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04706091",
"title": "Efficacy of Suvorexant in Patients With Effectively Treated Restless Legs Syndrome and Persistent Chronic Insomnia: A Randomized Placebo-Controlled Crossover Trial",
"has_exemption": false,
"start_date": "2021-08-12",
"completion_date": "2023-10-20",
"has_results": true,
"results_due": true,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05413369",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05413369",
"title": "A Randomized, 24 Weeks, Active-controlled, Open-label, 2-arm Multicenter Study Comparing the Efficacy and Safety of iGlarLixi to IDegAsp in Chinese Type 2 Diabetes Mellitus Participants Insufficiently Controlled With Oral Antidiabetic Drug(s)",
"has_exemption": false,
"start_date": "2022-07-07",
"completion_date": "2023-10-20",
"has_results": true,
"results_due": true,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05583955",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05583955",
"title": "A Double-blind, Placebo-controlled, Phase IIb, Multi-center, Ten-week Prospective Study to Evaluate the Efficacy and Safety of NOE-105 in Adult Male Patients With Childhood Onset Fluency Disorder (Orpheus)",
"has_exemption": false,
"start_date": "2022-07-25",
"completion_date": "2023-10-20",
"has_results": false,
"results_due": true,
"sponsor_name": "Noema Pharma AG",
"sponsor_slug": "noema-pharma-ag",
"status": "overdue",
"is_pact": false,
"days_late": 302
},
{
"registry_id": "NCT05388760",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05388760",
"title": "A Single (Assessor) Blinded, Randomized, Parallel-group, Monotherapy Trial to Evaluate the Pharmacokinetics and Safety of Tralokinumab in Children (Age 6 to <12 Years) With Moderate-to-severe Atopic Dermatitis",
"has_exemption": true,
"start_date": "2022-09-07",
"completion_date": "2023-10-20",
"has_results": false,
"results_due": false,
"sponsor_name": "LEO Pharma",
"sponsor_slug": "leo-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05555173",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05555173",
"title": "IVs With Buzzy in Chronic Pain Patients",
"has_exemption": false,
"start_date": "2022-10-01",
"completion_date": "2023-10-20",
"has_results": false,
"results_due": true,
"sponsor_name": "Steward St. Elizabeth's Medical Center of Boston, Inc.",
"sponsor_slug": "steward-st-elizabeths-medical-center-of-boston-inc",
"status": "overdue",
"is_pact": false,
"days_late": 302
},
{
"registry_id": "NCT05283304",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05283304",
"title": "Randomized, Double-blind, Placebo-controlled Trial of Monthly Injectable Buprenorphine (BUP) for Methamphetamine (MA) Use Disorder",
"has_exemption": false,
"start_date": "2023-03-24",
"completion_date": "2023-10-20",
"has_results": true,
"results_due": true,
"sponsor_name": "Madhukar H. Trivedi, MD",
"sponsor_slug": "madhukar-h-trivedi-md",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04603066",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04603066",
"title": "Administration of Ondansetron With P-glycoprotein Inhibitor Tariquidar in Patients With Neuropathic Pain",
"has_exemption": false,
"start_date": "2021-01-31",
"completion_date": "2023-10-21",
"has_results": true,
"results_due": true,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "reported-late",
"is_pact": false,
"days_late": 21
},
{
"registry_id": "NCT05321121",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05321121",
"title": "Dexmedotomidine for Acute Pain Control in Patients With Multiple Rib Fractures",
"has_exemption": false,
"start_date": "2021-11-12",
"completion_date": "2023-10-21",
"has_results": false,
"results_due": true,
"sponsor_name": "University of California, Irvine",
"sponsor_slug": "university-of-california-irvine",
"status": "reported-late",
"is_pact": false,
"days_late": 136
},
{
"registry_id": "NCT03616821",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03616821",
"title": "A 54-Week, Multicenter, Randomized, Double-blind, Placebo Controlled, Parallel-group Phase 2 Study to Assess the Efficacy and Safety of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis (Expedition Lead-in)",
"has_exemption": false,
"start_date": "2018-08-07",
"completion_date": "2023-10-23",
"has_results": false,
"results_due": true,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03575351",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03575351",
"title": "A Global Randomized Multicenter Phase 3 Trial of JCAR017 Compared to Standard of Care in Adult Subjects With High-risk, Second-line, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas (TRANSFORM).",
"has_exemption": false,
"start_date": "2018-10-23",
"completion_date": "2023-10-23",
"has_results": true,
"results_due": true,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03754465",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03754465",
"title": "A Phase 2 Clinical Study to Evaluate the Efficacy and Safety of ALLO-ASC-SHEET in Subjects with Diabetic Foot Ulcers",
"has_exemption": false,
"start_date": "2019-01-02",
"completion_date": "2023-10-23",
"has_results": false,
"results_due": true,
"sponsor_name": "Anterogen Co., Ltd.",
"sponsor_slug": "anterogen-co-ltd",
"status": "overdue",
"is_pact": false,
"days_late": 299
},
{
"registry_id": "NCT04269265",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04269265",
"title": "The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever Vaccination",
"has_exemption": false,
"start_date": "2020-07-01",
"completion_date": "2023-10-23",
"has_results": false,
"results_due": true,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "reported-late",
"is_pact": false,
"days_late": 292
},
{
"registry_id": "NCT04523207",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04523207",
"title": "A Multi-center, Open-label, Single-arm Phase 2 Study of the Adjuvant Treatment of Apalutamide and Androgen Deprivation Therapy (ADT) in Treatment-naïve Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases",
"has_exemption": false,
"start_date": "2020-08-19",
"completion_date": "2023-10-23",
"has_results": true,
"results_due": true,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "reported-late",
"is_pact": false,
"days_late": 2
},
{
"registry_id": "NCT04631601",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04631601",
"title": "A Master Protocol Evaluating the Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)",
"has_exemption": true,
"start_date": "2021-01-15",
"completion_date": "2023-10-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04968912",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04968912",
"title": "A Randomized, Placebo-controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)",
"has_exemption": true,
"start_date": "2021-09-21",
"completion_date": "2023-10-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06016127",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06016127",
"title": "A Single-center, Randomized, Pilot Study to Assess Iovera° Lumbar Medial Branch Cryoneurolysis vs Lumbar Radiofrequency Ablation for Facet Mediated Chronic Low Back Pain",
"has_exemption": false,
"start_date": "2022-06-18",
"completion_date": "2023-10-23",
"has_results": true,
"results_due": true,
"sponsor_name": "Medical Pain Management Services, PLLC",
"sponsor_slug": "medical-pain-management-services-pllc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05399771",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05399771",
"title": "Radiofrequency Hyperthermia Safety Study (RHySS)",
"has_exemption": false,
"start_date": "2022-06-27",
"completion_date": "2023-10-23",
"has_results": true,
"results_due": true,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05302596",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05302596",
"title": "Preserving Lean Body Mass During Weight Loss In Elderly Obese Patients With GLP-1 Receptor Agonist Treatment",
"has_exemption": false,
"start_date": "2022-09-01",
"completion_date": "2023-10-23",
"has_results": true,
"results_due": true,
"sponsor_name": "State University of New York at Buffalo",
"sponsor_slug": "state-university-of-new-york-at-buffalo",
"status": "reported-late",
"is_pact": false,
"days_late": 159
},
{
"registry_id": "NCT05565742",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05565742",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3819469 in Adults With Elevated Lipoprotein(a)",
"has_exemption": true,
"start_date": "2022-10-20",
"completion_date": "2023-10-23",
"has_results": true,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06173648",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06173648",
"title": "Histopathological Evaluation of the Periodontal Ligament and Cementum of Extracted Teeth Subjected to Laser Ablation With Indocyanine Green.",
"has_exemption": false,
"start_date": "2023-08-01",
"completion_date": "2023-10-23",
"has_results": true,
"results_due": true,
"sponsor_name": "CAO Group, Inc.",
"sponsor_slug": "cao-group-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03126331",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03126331",
"title": "A Single-arm Phase II Trial of Intermittent Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy",
"has_exemption": false,
"start_date": "2017-08-03",
"completion_date": "2023-10-24",
"has_results": false,
"results_due": true,
"sponsor_name": "Case Comprehensive Cancer Center",
"sponsor_slug": "case-comprehensive-cancer-center",
"status": "overdue",
"is_pact": false,
"days_late": 298
},
{
"registry_id": "NCT04025554",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04025554",
"title": "Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis",
"has_exemption": false,
"start_date": "2019-10-25",
"completion_date": "2023-10-24",
"has_results": true,
"results_due": true,
"sponsor_name": "National Institute of Neurological Disorders and Stroke (NINDS)",
"sponsor_slug": "national-institute-of-neurological-disorders-and-stroke-ninds",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04777422",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04777422",
"title": "A Pilot Study to Determine the Safety of Defibrotide in Children With High Risk Kawasaki Disease",
"has_exemption": false,
"start_date": "2021-02-24",
"completion_date": "2023-10-24",
"has_results": false,
"results_due": true,
"sponsor_name": "New York Medical College",
"sponsor_slug": "new-york-medical-college",
"status": "overdue",
"is_pact": false,
"days_late": 298
},
{
"registry_id": "NCT04880655",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04880655",
"title": "A Randomized, Controlled Study Evaluating a Surfactant-based Wound Dressing for Tissue Salvage and Reduction in Surgical Burden",
"has_exemption": false,
"start_date": "2021-08-03",
"completion_date": "2023-10-24",
"has_results": false,
"results_due": true,
"sponsor_name": "University of Tennessee",
"sponsor_slug": "university-of-tennessee",
"status": "overdue",
"is_pact": false,
"days_late": 298
},
{
"registry_id": "NCT04896476",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04896476",
"title": "Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae",
"has_exemption": false,
"start_date": "2022-01-21",
"completion_date": "2023-10-24",
"has_results": true,
"results_due": true,
"sponsor_name": "Sonavex, Inc.",
"sponsor_slug": "sonavex-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 26
},
{
"registry_id": "NCT04770493",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04770493",
"title": "Proof-of-Concept Clinical Trial of Lamotrigine as a Candidate Pharmacotherapy for Adolescent Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2022-01-24",
"completion_date": "2023-10-24",
"has_results": true,
"results_due": true,
"sponsor_name": "Brown University",
"sponsor_slug": "brown-university",
"status": "reported-late",
"is_pact": false,
"days_late": 174
},
{
"registry_id": "NCT05405309",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05405309",
"title": "A Phase Ib/II Trial of Combination RP-3500 and Olaparib in DNA Damage Repair Pathway Deficient Relapsed/Refractory Chronic Lymphocytic Leukemia",
"has_exemption": true,
"start_date": "2022-09-23",
"completion_date": "2023-10-24",
"has_results": true,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05574959",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05574959",
"title": "Clinical Investigation of the TECNIS® Next-Generation Intraocular Lens, Model DEN00V",
"has_exemption": true,
"start_date": "2022-10-24",
"completion_date": "2023-10-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Johnson & Johnson Surgical Vision, Inc.",
"sponsor_slug": "johnson-johnson-surgical-vision-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06168773",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06168773",
"title": "Combination of Haloperidol and Magnesium for Delirium Prevention in Critically Ill Elderly Patients After Elective Major Surgery",
"has_exemption": false,
"start_date": "2022-11-01",
"completion_date": "2023-10-24",
"has_results": false,
"results_due": true,
"sponsor_name": "Ain Shams University",
"sponsor_slug": "ain-shams-university",
"status": "overdue",
"is_pact": false,
"days_late": 298
},
{
"registry_id": "NCT03386578",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03386578",
"title": "Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for Primary HIV Prevention During Pregnancy and Postpartum in Adolescents and Young Women and Their Infants",
"has_exemption": false,
"start_date": "2018-07-03",
"completion_date": "2023-10-25",
"has_results": true,
"results_due": true,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04270591",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04270591",
"title": "A Phase Ib/II, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Glumetinib (SCC244), a Selective MET Inhibitor in Patients With Advanced Non-Small Cell Lung Cancer Harboring MET-alterations",
"has_exemption": false,
"start_date": "2019-07-15",
"completion_date": "2023-10-25",
"has_results": false,
"results_due": true,
"sponsor_name": "Haihe Biopharma Co., Ltd.",
"sponsor_slug": "haihe-biopharma-co-ltd",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04126603",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04126603",
"title": "Impact of Semaglutide (Long Acting GLP1 Agonist) on Peripheral Blood Derived CD34+ Endothelial Cells (EPCs) and Subcutaneous Fat Derived Mesenchymal Stromal Cells ( MSCs) in Type 2 Diabetes Subjects",
"has_exemption": false,
"start_date": "2019-08-01",
"completion_date": "2023-10-25",
"has_results": false,
"results_due": true,
"sponsor_name": "Sabyasachi Sen",
"sponsor_slug": "sabyasachi-sen",
"status": "reported-late",
"is_pact": false,
"days_late": 143
},
{
"registry_id": "NCT04924660",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04924660",
"title": "CONNECTS Master Protocol for Clinical Trials Targeting Macro-, Micro-immuno-thrombosis, Vascular Hyperinflammation, and Hypercoagulability and Renin-angiotensin-aldosterone System (RAAS) in Hospitalized Patients With COVID-19 (ACTIV-4 Host Tissue)",
"has_exemption": false,
"start_date": "2021-07-15",
"completion_date": "2023-10-25",
"has_results": true,
"results_due": true,
"sponsor_name": "Sean Collins",
"sponsor_slug": "sean-collins",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05543174",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05543174",
"title": "An Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of TAK-625 in the Treatment of Subjects With Alagille Syndrome",
"has_exemption": false,
"start_date": "2023-01-16",
"completion_date": "2023-10-25",
"has_results": true,
"results_due": true,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00585559",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT00585559",
"title": "Inhibition of Lipid Peroxidation and Cerebral Vasospasm by an Acetaminophen-Based Regimen in Patients With Aneurysmal Subarachnoid Hemorrhage",
"has_exemption": false,
"start_date": "2007-04-30",
"completion_date": "2023-10-26",
"has_results": true,
"results_due": true,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "reported-late",
"is_pact": true,
"days_late": 128
},
{
"registry_id": "NCT01908192",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01908192",
"title": "An Adaptive, Phase IIb/III, Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy OF NaBen® , A D-Amino Acid Oxidase Inhibitor, as an Add-on Treatment for Schizophrenia in Adolescents",
"has_exemption": false,
"start_date": "2014-06-30",
"completion_date": "2023-10-26",
"has_results": false,
"results_due": true,
"sponsor_name": "SyneuRx International (Taiwan) Corp",
"sponsor_slug": "syneurx-international-taiwan-corp",
"status": "overdue",
"is_pact": true,
"days_late": 296
},
{
"registry_id": "NCT02791230",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02791230",
"title": "A PHASE 3 MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826-83) 20 MG OR 80 MG [OR TAFAMIDIS (PF-06291826-00) 61 MG] IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (ATTR-CM)",
"has_exemption": false,
"start_date": "2016-06-13",
"completion_date": "2023-10-26",
"has_results": true,
"results_due": true,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03250676",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03250676",
"title": "A Phase 1-2 Multicenter, Open Label Trial of H3B-6545, a Covalent Antagonist of Estrogen Receptor Alpha, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer",
"has_exemption": false,
"start_date": "2017-08-23",
"completion_date": "2023-10-26",
"has_results": true,
"results_due": true,
"sponsor_name": "Eisai Inc.",
"sponsor_slug": "eisai-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03910387",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03910387",
"title": "Weight Loss in Patients With Advanced Stage Pancreatic Cancer: Role of Serotonin and Effects of Telotristat Ethyl",
"has_exemption": false,
"start_date": "2019-04-17",
"completion_date": "2023-10-26",
"has_results": false,
"results_due": true,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "reported-late",
"is_pact": false,
"days_late": 240
},
{
"registry_id": "NCT04252742",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04252742",
"title": "Comprehensive Assessment of Erenumab Efficacy in Subjects With High Frequency Episodic Migraine With at Least 1 Previously Failed Preventive Treatment: a Global, Double-blind, Placebo-controlled Phase 4 Study",
"has_exemption": false,
"start_date": "2020-09-15",
"completion_date": "2023-10-26",
"has_results": true,
"results_due": true,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04612790",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04612790",
"title": "A Multinational, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Investigate the Use of Benralizumab as a Treatment Option for Patients With Bullous Pemphigoid (FJORD)",
"has_exemption": false,
"start_date": "2021-03-31",
"completion_date": "2023-10-26",
"has_results": true,
"results_due": true,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04825288",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04825288",
"title": "A Phase I/II Randomized, Double-blind, Placebo-controlled Trial (1-BETTER) Examining XB2001 (Anti-IL-1⍺ True Human Antibody) in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer",
"has_exemption": false,
"start_date": "2021-05-27",
"completion_date": "2023-10-26",
"has_results": false,
"results_due": true,
"sponsor_name": "XBiotech, Inc.",
"sponsor_slug": "xbiotech-inc",
"status": "overdue",
"is_pact": false,
"days_late": 296
},
{
"registry_id": "NCT05054374",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05054374",
"title": "A Phase 1b / 2a, Open-label Platform Study to Evaluate Mirdametinib as Monotherapy or in Combination With Other Anticancer Agents in Patients With Advanced Solid Cancers Harboring MAPK-activating Mutations",
"has_exemption": false,
"start_date": "2021-09-14",
"completion_date": "2023-10-26",
"has_results": true,
"results_due": true,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04951479",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04951479",
"title": "Geniculate Artery Embolization for Knee Osteoarthritis",
"has_exemption": false,
"start_date": "2021-11-03",
"completion_date": "2023-10-26",
"has_results": true,
"results_due": true,
"sponsor_name": "Anish Ghodadra",
"sponsor_slug": "anish-ghodadra",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04999020",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04999020",
"title": "A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Dermatomyositis",
"has_exemption": false,
"start_date": "2021-11-19",
"completion_date": "2023-10-26",
"has_results": true,
"results_due": true,
"sponsor_name": "Alexion Pharmaceuticals, Inc.",
"sponsor_slug": "alexion-pharmaceuticals-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04978818",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04978818",
"title": "Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children",
"has_exemption": false,
"start_date": "2022-01-27",
"completion_date": "2023-10-26",
"has_results": true,
"results_due": true,
"sponsor_name": "Johns Hopkins Bloomberg School of Public Health",
"sponsor_slug": "johns-hopkins-bloomberg-school-of-public-health",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04878432",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04878432",
"title": "Single-arm, Open Label, Phase II Study of MBG453 (Sabatolimab) Added to FDA Approved Hypomethylating Agents of Investigator's Choice (IV/SC/Oral) for Patients With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R Criteria (US Multi-center) (STIMULUS MDS-US)",
"has_exemption": true,
"start_date": "2022-03-17",
"completion_date": "2023-10-26",
"has_results": true,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05432596",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05432596",
"title": "A Phase 2b, Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis (AD)",
"has_exemption": true,
"start_date": "2022-05-11",
"completion_date": "2023-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Aclaris Therapeutics, Inc.",
"sponsor_slug": "aclaris-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05269667",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05269667",
"title": "SAkuraBonsai: Clinical, Imaging And Biomarker Open-Label Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention",
"has_exemption": false,
"start_date": "2022-08-02",
"completion_date": "2023-10-26",
"has_results": true,
"results_due": true,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05447663",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05447663",
"title": "A Phase Ib/II, Open Label Study of Siremadlin Monotherapy and in Combination With Donor Lymphocyte Infusion as a Treatment for Patients With Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplantation Who Are in Complete Remission But at High Risk for Relapse.",
"has_exemption": false,
"start_date": "2023-02-23",
"completion_date": "2023-10-26",
"has_results": true,
"results_due": true,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05691972",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05691972",
"title": "A Randomized, No-treatment-controlled, Evaluator-blinded, Multi-center Study to Evaluate the Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing",
"has_exemption": true,
"start_date": "2023-03-14",
"completion_date": "2023-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Galderma R&D",
"sponsor_slug": "galderma-rd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00378482",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT00378482",
"title": "A Rollover Protocol For Patients Who Received Tremelimumab (CP-675,206 ) In Other Protocols",
"has_exemption": false,
"start_date": "2007-03-05",
"completion_date": "2023-10-27",
"has_results": true,
"results_due": true,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04000607",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04000607",
"title": "Exploratory Study of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW Canada)",
"has_exemption": true,
"start_date": "2019-01-01",
"completion_date": "2023-10-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Edwards Lifesciences",
"sponsor_slug": "edwards-lifesciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05546047",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05546047",
"title": "A Multicenter, Comparative Safety and Efficacy Study of ACTHar Gel Alone or in Combination With Oral Tacrolimus to Reduce Urinary Proteinuria in Patients With Idiopathic DNAJB9 Positive Fibrillary Glomerulopathy",
"has_exemption": false,
"start_date": "2019-03-14",
"completion_date": "2023-10-27",
"has_results": false,
"results_due": true,
"sponsor_name": "NephroNet, Inc.",
"sponsor_slug": "nephronet-inc",
"status": "overdue",
"is_pact": false,
"days_late": 295
},
{
"registry_id": "NCT04084366",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04084366",
"title": "A Phase 1/2, Open-Label, Dose-Escalation and Cohort-Expansion Study Evaluating the Safety, Pharmacokinetics, and Therapeutic Activity of OBI-999 in Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2019-11-25",
"completion_date": "2023-10-27",
"has_results": true,
"results_due": true,
"sponsor_name": "OBI Pharma, Inc",
"sponsor_slug": "obi-pharma-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 101
},
{
"registry_id": "NCT04424316",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04424316",
"title": "A PHASE 3, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY",
"has_exemption": false,
"start_date": "2020-06-17",
"completion_date": "2023-10-27",
"has_results": true,
"results_due": true,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04786119",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04786119",
"title": "A Prospective, Multi-center, Study to Evaluate the Safety and Effectiveness of REAL INTELLIGENCE™ CORI™ in Unicondylar Knee Arthroplasty (UKA) and Total Knee Arthroplasty (TKA) Procedures",
"has_exemption": false,
"start_date": "2021-02-17",
"completion_date": "2023-10-27",
"has_results": true,
"results_due": true,
"sponsor_name": "Smith & Nephew, Inc.",
"sponsor_slug": "smith-nephew-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 37
},
{
"registry_id": "NCT04869787",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04869787",
"title": "A Multi-Center, Pilot Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device (SCD) for the Treatment of Immunomodulatory Dysregulation Due to Pediatric Acute Kidney Injury (AKI)",
"has_exemption": false,
"start_date": "2021-05-17",
"completion_date": "2023-10-27",
"has_results": true,
"results_due": true,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05111249",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05111249",
"title": "A Randomized, Double-Blind, Placebo-Controlled Dose Range Finding Study With Open-Label Extension to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of LMI070/Branaplam Administered as Weekly Oral Doses in Participants With Early Manifest Huntington's Disease",
"has_exemption": false,
"start_date": "2021-12-08",
"completion_date": "2023-10-27",
"has_results": true,
"results_due": true,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05307510",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05307510",
"title": "Influence of Custom Orthosis Post Carpometacarpal CMC) Arthroplasty",
"has_exemption": false,
"start_date": "2022-04-21",
"completion_date": "2023-10-27",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Toledo",
"sponsor_slug": "university-of-toledo",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05608343",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05608343",
"title": "A Phase 3, Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Assess the Efficacy and Safety of Difamilast Ointment 1% in Children, Adolescents, and Adults With Mild to Moderate Atopic Dermatitis",
"has_exemption": true,
"start_date": "2022-10-01",
"completion_date": "2023-10-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Acrotech Biopharma Inc.",
"sponsor_slug": "acrotech-biopharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05513053",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05513053",
"title": "Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) in Children and Adolescents Aged 9 to 17 Years and Adults Aged 18 to 49 Years.",
"has_exemption": false,
"start_date": "2022-10-27",
"completion_date": "2023-10-27",
"has_results": true,
"results_due": true,
"sponsor_name": "Sanofi Pasteur, a Sanofi Company",
"sponsor_slug": "sanofi-pasteur-a-sanofi-company",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05852470",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05852470",
"title": "PMCF (Post Market Clinical Follow-up) Evaluation of Clareon Vivity/Vivity Toric",
"has_exemption": false,
"start_date": "2023-05-23",
"completion_date": "2023-10-27",
"has_results": true,
"results_due": true,
"sponsor_name": "Alcon Research",
"sponsor_slug": "alcon-research",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05478551",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05478551",
"title": "Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization",
"has_exemption": false,
"start_date": "2022-06-01",
"completion_date": "2023-10-28",
"has_results": false,
"results_due": true,
"sponsor_name": "Henry Ford Health System",
"sponsor_slug": "henry-ford-health-system",
"status": "overdue",
"is_pact": false,
"days_late": 294
},
{
"registry_id": "NCT05321394",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05321394",
"title": "Adaptive, Randomized, Non-inferiority Trial on the Use of Monoclonal Antibodies or Antivirals in Outpatients With Mild or Moderate COVID-19",
"has_exemption": false,
"start_date": "2022-03-07",
"completion_date": "2023-10-29",
"has_results": false,
"results_due": true,
"sponsor_name": "Azienda Ospedaliera Universitaria Integrata Verona",
"sponsor_slug": "azienda-ospedaliera-universitaria-integrata-verona",
"status": "overdue",
"is_pact": false,
"days_late": 293
},
{
"registry_id": "NCT02352896",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02352896",
"title": "Long-Term Safety and Efficacy Evaluation of Vatiquinone (EPI-743) in Children With Leigh Syndrome",
"has_exemption": true,
"start_date": "2014-01-31",
"completion_date": "2023-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "PTC Therapeutics",
"sponsor_slug": "ptc-therapeutics",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02461927",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02461927",
"title": "Ketamine for The Rapid Treatment of Major Depression and Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2015-01-01",
"completion_date": "2023-10-30",
"has_results": true,
"results_due": true,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02927236",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02927236",
"title": "Neuroplasticity Following Theta-Burst Stimulation in Cocaine Use Disorder",
"has_exemption": false,
"start_date": "2017-02-13",
"completion_date": "2023-10-30",
"has_results": true,
"results_due": true,
"sponsor_name": "National Institute on Drug Abuse (NIDA)",
"sponsor_slug": "national-institute-on-drug-abuse-nida",
"status": "reported",
"is_pact": false,
"days_late": null
}
]
}